NVIDIA CORP, 10-K filed on 2/21/2024
Annual Report
v3.24.0.1
Cover Page - USD ($)
shares in Billions, $ in Trillions
12 Months Ended
Jan. 28, 2024
Feb. 16, 2024
Jul. 28, 2023
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Jan. 28, 2024    
Current Fiscal Year End Date --01-28    
Document Transition Report false    
Entity File Number 0-23985    
Entity Registrant Name NVIDIA CORP    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 94-3177549    
Entity Address, Address Line One 2788 San Tomas Expressway    
Entity Address, City or Town Santa Clara    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 95051    
City Area Code 408    
Local Phone Number 486-2000    
Title of 12(b) Security Common Stock, $0.001 par value per share    
Trading Symbol NVDA    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 1.1
Entity Common Stock, Shares Outstanding   2.5  
Documents Incorporated by Reference
Portions of the registrant's Proxy Statement for its 2024 Annual Meeting of Shareholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K are incorporated by reference into Part III, Items 10-14 of this Annual Report on Form 10-K.
   
Entity Central Index Key 0001045810    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
Amendment Flag false    
v3.24.0.1
Audit Information
12 Months Ended
Jan. 28, 2024
Audit Information [Abstract]  
Auditor Firm ID 238
Auditor Name PricewaterhouseCoopers LLP
Auditor Location San Jose, California
v3.24.0.1
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Income Statement [Abstract]      
Revenue $ 60,922 $ 26,974 $ 26,914
Cost of revenue 16,621 11,618 9,439
Gross profit 44,301 15,356 17,475
Operating expenses      
Research and development 8,675 7,339 5,268
Sales, general and administrative 2,654 2,440 2,166
Acquisition termination cost 0 1,353 0
Total operating expenses 11,329 11,132 7,434
Operating income 32,972 4,224 10,041
Interest income 866 267 29
Interest expense (257) (262) (236)
Other, net 237 (48) 107
Other income (expense), net 846 (43) (100)
Income before income tax 33,818 4,181 9,941
Income tax expense (benefit) 4,058 (187) 189
Net income $ 29,760 $ 4,368 $ 9,752
Net income per share:      
Basic (in USD per share) $ 12.05 $ 1.76 $ 3.91
Diluted (in USD per share) $ 11.93 $ 1.74 $ 3.85
Weighted average shares used in per share computation:      
Basic (in shares) 2,469 2,487 2,496
Diluted (in shares) 2,494 2,507 2,535
v3.24.0.1
Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Statement of Comprehensive Income [Abstract]      
Net income $ 29,760 $ 4,368 $ 9,752
Available-for-sale securities:      
Net change in unrealized gain (loss) 80 (31) (16)
Reclassification adjustments for net realized gain included in net income 0 1 0
Net change in unrealized gain (loss) 80 (30) (16)
Cash flow hedges:      
Net change in unrealized gain (loss) 38 47 (43)
Reclassification adjustments for net realized gain (loss) included in net income (48) (49) 29
Net change in unrealized loss (10) (2) (14)
Other comprehensive income (loss), net of tax 70 (32) (30)
Total comprehensive income $ 29,830 $ 4,336 $ 9,722
v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Jan. 28, 2024
Jan. 29, 2023
Current assets:    
Cash and cash equivalents $ 7,280 $ 3,389
Marketable securities 18,704 9,907
Accounts receivable, net 9,999 3,827
Inventories 5,282 5,159
Prepaid expenses and other current assets 3,080 791
Total current assets 44,345 23,073
Property and equipment, net 3,914 3,807
Operating lease assets 1,346 1,038
Goodwill 4,430 4,372
Intangible assets, net 1,112 1,676
Deferred income tax assets 6,081 3,396
Other assets 4,500 3,820
Total assets 65,728 41,182
Current liabilities:    
Accounts payable 2,699 1,193
Accrued and other current liabilities 6,682 4,120
Short-term debt 1,250 1,250
Total current liabilities 10,631 6,563
Long-term debt 8,459 9,703
Long-term operating lease liabilities 1,119 902
Other long-term liabilities 2,541 1,913
Total liabilities 22,750 19,081
Commitments and contingencies - see Note 13
Shareholders’ equity:    
Preferred stock, $0.001 par value; 2 shares authorized; none issued 0 0
Common stock, $0.001 par value; 8,000 shares authorized; 2,464 shares issued and outstanding as of January 28, 2024; 2,466 shares issued and outstanding as of January 29, 2023 2 2
Additional paid-in capital 13,132 11,971
Accumulated other comprehensive income (loss) 27 (43)
Retained earnings 29,817 10,171
Total shareholders' equity 42,978 22,101
Total liabilities and shareholders' equity $ 65,728 $ 41,182
v3.24.0.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
shares in Millions
Jan. 28, 2024
Jan. 29, 2023
Statement of Financial Position [Abstract]    
Preferred stock, par value (in USD per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 2 2
Preferred stock, shares issued (in shares) 0 0
Common stock, par value (in USD per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 8,000 8,000
Common stock, shares issued (in shares) 2,464 2,466
Common stock, shares outstanding (in shares) 2,464 2,466
v3.24.0.1
Consolidated Statements of Shareholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock Outstanding
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance, common stock outstanding (in shares) at Jan. 31, 2021   2,479        
Beginning balances, shareholders' equity at Jan. 31, 2021 $ 16,893 $ 3 $ 8,719 $ (10,756) $ 19 $ 18,908
Increase (Decrease) in Shareholders' Equity            
Net income 9,752         9,752
Other comprehensive (loss) income (30)       (30)  
Issuance of common stock from stock plans (in shares)   35        
Issuance of common stock from stock plans 281   281      
Tax withholding related to vesting of restricted stock units (in shares)   (8)        
Tax withholding related to vesting of restricted stock units (1,904)   (614) (1,290)    
Cash dividends declared and paid (399)         (399)
Fair value of partially vested equity awards assumed in connection with acquisitions 18   18      
Stock-based compensation 2,001   2,001      
Retirement of Treasury Stock 0   (20) 12,046   (12,026)
Ending balance, common stock outstanding (in shares) at Jan. 30, 2022   2,506        
Ending balances, shareholders' equity at Jan. 30, 2022 $ 26,612 $ 3 10,385 0 (11) 16,235
Increase (Decrease) in Shareholders' Equity            
Cash dividends declared and paid (USD per common share) $ 0.16          
Net income $ 4,368         4,368
Other comprehensive (loss) income (32)       (32)  
Issuance of common stock from stock plans (in shares)   31        
Issuance of common stock from stock plans 355   355      
Tax withholding related to vesting of restricted stock units (in shares)   (8)        
Tax withholding related to vesting of restricted stock units (1,475)   (1,475)      
Share repurchased (in shares)   (63)        
Shares repurchased (10,039) $ (1) (4)     (10,034)
Cash dividends declared and paid (398)         (398)
Stock-based compensation $ 2,710   2,710      
Ending balance, common stock outstanding (in shares) at Jan. 29, 2023 2,466 2,466        
Ending balances, shareholders' equity at Jan. 29, 2023 $ 22,101 $ 2 11,971 0 (43) 10,171
Increase (Decrease) in Shareholders' Equity            
Cash dividends declared and paid (USD per common share) $ 0.16          
Net income $ 29,760         29,760
Other comprehensive (loss) income 70       70  
Issuance of common stock from stock plans (in shares)   26        
Issuance of common stock from stock plans 403   403      
Tax withholding related to vesting of restricted stock units (in shares)   (7)        
Tax withholding related to vesting of restricted stock units $ (2,783)   (2,783)      
Share repurchased (in shares) (21) (21)        
Shares repurchased $ (9,746)   (27)     (9,719)
Cash dividends declared and paid (395)         (395)
Stock-based compensation $ 3,568   3,568      
Ending balance, common stock outstanding (in shares) at Jan. 28, 2024 2,464 2,464        
Ending balances, shareholders' equity at Jan. 28, 2024 $ 42,978 $ 2 $ 13,132 $ 0 $ 27 $ 29,817
Increase (Decrease) in Shareholders' Equity            
Cash dividends declared and paid (USD per common share) $ 0.16          
v3.24.0.1
Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Statement of Stockholders' Equity [Abstract]      
Cash dividends declared and paid (USD per common share) $ 0.16 $ 0.16 $ 0.16
Cash dividends declared and paid (USD per common share) $ 0.16 $ 0.16 $ 0.16
v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Cash flows from operating activities:      
Net income $ 29,760 $ 4,368 $ 9,752
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation expense 3,549 2,709 2,004
Depreciation and amortization 1,508 1,544 1,174
Deferred income taxes (2,489) (2,164) (406)
(Gains) losses on investments in non-affiliated entities, net (238) 45 (100)
Acquisition termination cost 0 1,353 0
Other (278) (7) 47
Changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable (6,172) 822 (2,215)
Inventories (98) (2,554) (774)
Prepaid expenses and other assets (1,522) (1,517) (1,715)
Accounts payable 1,531 (551) 568
Accrued and other current liabilities 2,025 1,341 581
Other long-term liabilities 514 252 192
Net cash provided by operating activities 28,090 5,641 9,108
Cash flows from investing activities:      
Proceeds from maturities of marketable securities 9,732 19,425 15,197
Proceeds from sales of marketable securities 50 1,806 1,023
Purchases of marketable securities (18,211) (11,897) (24,787)
Purchases related to property and equipment and intangible assets (1,069) (1,833) (976)
Acquisitions, net of cash acquired (83) (49) (263)
Investments in non-affiliated entities and other, net (985) (77) (24)
Net cash provided by (used in) investing activities (10,566) 7,375 (9,830)
Cash flows from financing activities:      
Proceeds related to employee stock plans 403 355 281
Payments related to repurchases of common stock (9,533) (10,039) 0
Payments related to tax on restricted stock units (2,783) (1,475) (1,904)
Repayment of debt (1,250) 0 (1,000)
Dividends paid (395) (398) (399)
Principal payments on property and equipment and intangible assets (74) (58) (83)
Issuance of debt, net of issuance costs 0 0 4,977
Other (1) (2) (7)
Net cash provided by (used in) financing activities (13,633) (11,617) 1,865
Change in cash and cash equivalents 3,891 1,399 1,143
Cash and cash equivalents at beginning of period 3,389 1,990 847
Cash and cash equivalents at end of period 7,280 3,389 1,990
Supplemental disclosures of cash flow information:      
Cash paid for income taxes, net 6,549 1,404 396
Cash paid for interest $ 252 $ 254 $ 246
v3.24.0.1
Organization and Summary of Significant Accounting Policies
12 Months Ended
Jan. 28, 2024
Accounting Policies [Abstract]  
Organization and Summary of Significant Accounting Policies Organization and Summary of Significant Accounting Policies
Our Company
Headquartered in Santa Clara, California, NVIDIA was incorporated in California in April 1993 and reincorporated in Delaware in April 1998.
All references to “NVIDIA,” “we,” “us,” “our” or the “Company” mean NVIDIA Corporation and its subsidiaries.
Fiscal Year
We operate on a 52- or 53-week year, ending on the last Sunday in January. Fiscal years 2024, 2023 and 2022 were all 52-week years.
Principles of Consolidation
Our consolidated financial statements include the accounts of NVIDIA Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from our estimates. On an on-going basis, we evaluate our estimates, including those related to revenue recognition, cash equivalents and marketable securities, accounts receivable, inventories and product purchase commitments, income taxes, goodwill, stock-based compensation, litigation, investigation and settlement costs, restructuring and other charges, property, plant, and equipment, and other contingencies. These estimates are based on historical facts and various other assumptions that we believe are reasonable.
In February 2023, we assessed the useful lives of our property, plant, and equipment. Based on advances in technology and usage rate, we increased the estimated useful life of most of our server, storage, and network equipment from three to four or five years, and our assembly and test equipment from five to seven years. The effect of this change for the fiscal year ended January 28, 2024 was a benefit of $33 million and $102 million for cost of revenue and operating expenses, respectively, which resulted in an increase in operating income of $135 million and net income of $114 million after tax, or $0.05 per both basic and diluted share.
Revenue Recognition
We derive our revenue from product sales, including hardware and systems, license and development arrangements, software licensing, and cloud services. We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract (where revenue is allocated on a relative standalone selling price basis by maximizing the use of observable inputs to determine the standalone selling price for each performance obligation); and (5) recognition of revenue when, or as, we satisfy a performance obligation.
Product Sales Revenue
Revenue from product sales is recognized upon transfer of control of products to customers in an amount that reflects the consideration we expect to receive in exchange for those products. Certain products are sold with support or an extended warranty for the incorporated system, hardware, and/or software. Support and extended warranty revenue are recognized ratably over the service period, or as services are performed. Revenue is recognized net of allowances for returns, customer programs and any taxes collected from customers.
For products sold with a right of return, we record a reduction to revenue by establishing a sales return allowance for estimated product returns at the time revenue is recognized, based primarily on historical return rates. However, if product returns for a fiscal period are anticipated to exceed historical return rates, we may determine that additional sales return allowances are required to accurately reflect our estimated exposure for product returns.
Our customer programs involve rebates, which are designed to serve as sales incentives to resellers of our products in various target markets, and marketing development funds, or MDFs, which represent monies paid to our partners that are earmarked for market segment development and are designed to support our partners’ activities while also promoting NVIDIA products. We account for customer programs as a reduction to revenue and accrue for such programs for potential rebates and MDFs based on the amount we expect to be claimed by customers.
License and Development Arrangements
Our license and development arrangements with customers typically require significant customization of our IP components. As a result, we recognize the revenue from the license and the revenue from the development services as a single performance obligation over the period in which the development services are performed. We measure progress to completion based on actual cost incurred to date as a percentage of the estimated total cost required to complete each project. If a loss on an arrangement becomes probable during a period, we record a provision for such loss in that period.
Software Licensing
Our software licenses provide our customers with a right to use the software when it is made available to the customer. Customers may purchase either perpetual licenses or subscriptions to licenses, which differ mainly in the duration over which the customer benefits from the software. Software licenses are frequently sold along with the right to receive, on a when-and-if available basis, future unspecified software updates and upgrades. Revenue from software licenses is recognized up front when the software is made available to the customer. Software support revenue is recognized ratably over the service period, or as services are performed.
Cloud Services
Cloud services, which allow customers to use hosted software and hardware infrastructure without taking possession of the software or hardware, are provided on a subscription basis or a combination of subscription plus usage. Revenue related to subscription-based cloud services is recognized ratably over the contract period. Revenue related to cloud services based on usage is recognized as usage occurs. Cloud services are typically sold on a standalone basis, but certain offerings may be sold with hardware and/or software and related support.
Contracts with Multiple Performance Obligations
Our contracts may contain more than one of the products and services listed above, each of which is separately accounted for as a distinct performance obligation. We account for multiple agreements with a single customer as a single contract if the contractual terms and/or substance of those agreements indicate that they may be so closely related that they are, in effect, parts of a single contract.
We allocate the total transaction price to each distinct performance obligation in a multiple performance obligations arrangement on a relative standalone selling price basis. The standalone selling price reflects the price we would charge for a specific product or service if it were sold separately in similar circumstances and to similar customers. When determining standalone selling price, we maximize the use of observable inputs.
If a contract contains a single performance obligation, no allocation is required.
Product Warranties
We offer a limited warranty to end-users ranging from one to three years for products to repair or replace products for manufacturing defects or hardware component failures. Cost of revenue includes the estimated cost of product warranties that are calculated at the point of revenue recognition. Under limited circumstances, we may offer an extended limited warranty to customers for certain products. We also accrue for known warranty and indemnification issues if a loss is probable and can be reasonably estimated.
Stock-based Compensation
We use the closing trading price of our common stock on the date of grant, minus a dividend yield discount, as the fair value of awards of restricted stock units, or RSUs, and performance stock units that are based on our corporate financial performance targets, or PSUs. We use a Monte Carlo simulation on the date of grant to estimate the fair value of performance stock units that are based on market conditions, or market-based PSUs. The compensation expense for RSUs and market-based PSUs is recognized using a straight-line attribution method over the requisite employee service period while compensation expense for PSUs is recognized using an accelerated amortization model. We estimate the fair value of shares to be issued under our employee stock purchase plan, or ESPP, using the Black-Scholes model at the commencement of an offering period in March and September of each year. Stock-based compensation for our ESPP is expensed using an accelerated amortization model. Additionally, for RSU, PSU, and market-based PSU awards, we estimate forfeitures semi-annually and revise the estimates of forfeiture in subsequent periods if actual forfeitures differ from those estimates. Forfeitures are estimated based on historical experience.
Litigation, Investigation and Settlement Costs
We currently, are, and will likely continue to be subject to claims, litigation, and other actions, including potential regulatory proceedings, involving patent and other intellectual property matters, taxes, labor and employment, competition and antitrust, commercial disputes, goods and services offered by us and by third parties, and other matters. There are many uncertainties associated with any litigation or investigation, and we cannot be certain that these actions
or other third-party claims against us will be resolved without litigation, fines and/or substantial settlement payments or judgments. If information becomes available that causes us to determine that a loss in any of our pending litigation, investigations or settlements is probable, and we can reasonably estimate the loss associated with such events, we will record the loss in accordance with U.S. GAAP. However, the actual liability in any such litigation or investigation may be materially different from our estimates, which could require us to record additional costs.
Foreign Currency Remeasurement
We use the U.S. dollar as our functional currency for our subsidiaries. Foreign currency monetary assets and liabilities are remeasured into United States dollars at end-of-period exchange rates. Non-monetary assets and liabilities such as property and equipment and equity are remeasured at historical exchange rates. Revenue and expenses are remeasured at exchange rates in effect during each period, except for those expenses related to non-monetary balance sheet amounts, which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in earnings in our Consolidated Statements of Income and to date have not been significant.
Income Taxes
We recognize federal, state and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. We recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects attributable to temporary differences and carryforwards; and we record a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment, are not expected to be realized.
Our calculation of deferred tax assets and liabilities is based on certain estimates and judgments and involves dealing with uncertainties in the application of complex tax laws. Our estimates of deferred tax assets and liabilities may change based, in part, on added certainty or finality to an anticipated outcome, changes in accounting standards or tax laws in the U.S., or foreign jurisdictions where we operate, or changes in other facts or circumstances. In addition, we recognize liabilities for potential U.S. and foreign income tax contingencies based on our estimate of whether, and the extent to which, additional taxes may be due. If we determine that payment of these amounts is unnecessary or if the recorded tax liability is less than our current assessment, we may be required to recognize an income tax benefit or additional income tax expense in our financial statements accordingly.
As of January 28, 2024, we had a valuation allowance of $1.6 billion related to capital loss carryforwards, and certain state and other deferred tax assets that management determined are not likely to be realized due, in part, to jurisdictional projections of future taxable income, including capital gains. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax assets as income tax benefits during the period.
We recognize the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. Our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense.
Net Income Per Share
Basic net income per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common and potentially dilutive shares outstanding during the period, using the treasury stock method. Any anti-dilutive effect of equity awards outstanding is not included in the computation of diluted net income per share.
Cash and Cash Equivalents and Marketable Securities
We consider all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents. Marketable securities consist of highly liquid debt investments with maturities of greater than three months when purchased. We currently classify our investments as current based on the nature of the investments and their availability for use in current operations.
We classify our cash equivalents and marketable securities related to debt securities at the date of acquisition as available-for-sale. These available-for-sale debt securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. The fair value of interest-bearing debt securities includes accrued interest. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in the other income (expense), net, section of our Consolidated Statements of Income.
Available-for-sale debt investments are subject to a periodic impairment review. If the estimated fair value of available-for-sale debt securities is less than its amortized cost basis, we determine if the difference, if any, is caused by expected credit losses and write-down the amortized cost basis of the securities if it is more likely than not we will be required or
we intend to sell the securities before recovery of its amortized cost basis. Allowances for credit losses and write-downs are recognized in the other income (expense), net section of our Consolidated Statements of Income.
Fair Value of Financial Instruments
The carrying value of cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their relatively short maturities as of January 28, 2024 and January 29, 2023. Marketable securities are comprised of available-for-sale securities that are reported at fair value with the related unrealized gains or losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. Fair value of the marketable securities is determined based on quoted market prices. Derivative instruments are recognized as either assets or liabilities and are measured at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. For derivative instruments designated as fair value hedges, the gains or losses are recognized in earnings in the periods of change together with the offsetting losses or gains on the hedged items attributed to the risk being hedged. For derivative instruments designated as cash-flow hedges, the effective portion of the gains or losses on the derivatives is initially reported as a component of other comprehensive income or loss and is subsequently recognized in earnings when the hedged exposure is recognized in earnings. For derivative instruments not designated for hedge accounting, changes in fair value are recognized in earnings.
Concentration of Credit Risk
Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, marketable securities, and accounts receivable. Our investment policy requires the purchase of highly-rated fixed income securities, the diversification of investment type and credit exposures, and includes certain limits on our portfolio duration. We perform ongoing credit evaluations of our customers’ financial condition and maintain an allowance for potential credit losses. This allowance consists of an amount identified for specific customers and an amount based on overall estimated exposure. Our overall estimated exposure excludes amounts covered by credit insurance and letters of credit.
Inventories
Inventory cost is computed on an adjusted standard basis, which approximates actual cost on an average or first-in, first-out basis. Inventory costs consist primarily of the cost of semiconductors, including wafer fabrication, assembly, testing and packaging, manufacturing support costs, including labor and overhead associated with such purchases, final test yield fallout, and shipping costs, as well as the cost of purchased memory products and other component parts. We charge cost of sales for inventory provisions to write-down our inventory to the lower of cost or net realizable value or for obsolete or excess inventory, and for excess product purchase commitments. Most of our inventory provisions relate to excess quantities of products, based on our inventory levels and future product purchase commitments compared to assumptions about future demand and market conditions. Once inventory has been written-off or written-down, it creates a new cost basis for the inventory that is not subsequently written-up. We record a liability for noncancelable purchase commitments with suppliers for quantities in excess of our future demand forecasts consistent with our valuation of obsolete or excess inventory.
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation. Depreciation of property and equipment is computed using the straight-line method based on the estimated useful lives of the assets of three to seven years. Once an asset is identified for retirement or disposition, the related cost and accumulated depreciation or amortization are removed, and a gain or loss is recorded. The estimated useful lives of our buildings are up to thirty years. Depreciation expense includes the amortization of assets recorded under finance leases. Leasehold improvements and assets recorded under finance leases are amortized over the shorter of the expected lease term or the estimated useful life of the asset.
Leases
We determine if an arrangement is or contains a lease at inception. Operating leases with lease terms of more than 12 months are included in operating lease assets, accrued and other current liabilities, and long-term operating lease liabilities on our consolidated balance sheet. Operating lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments over the lease term.
Operating lease assets and liabilities are recognized based on the present value of the remaining lease payments discounted using our incremental borrowing rate. Operating lease assets also include initial direct costs incurred and prepaid lease payments, minus any lease incentives. Our lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense is recognized on a straight-line basis over the lease term.
We combine the lease and non-lease components in determining the operating lease assets and liabilities.
Goodwill
Goodwill is subject to our annual impairment test during the fourth quarter of our fiscal year, or earlier if indicators of potential impairment exist. In completing our impairment test, we perform either a qualitative or a quantitative analysis on a reporting unit basis. 
Qualitative factors include industry and market considerations, overall financial performance, and other relevant events and factors affecting the reporting units.
The quantitative impairment test considers both the income approach and the market approach to estimate a reporting unit’s fair value. The income and market valuation approaches consider factors that include, but are not limited to, prospective financial information, growth rates, residual values, discount rates and comparable multiples from publicly traded companies in our industry and require us to make certain assumptions and estimates regarding industry economic factors and the future profitability of our business. 
Intangible Assets and Other Long-Lived Assets
Intangible assets primarily represent acquired intangible assets including developed technology and customer relationships, as well as rights acquired under technology licenses, patents, and acquired IP. We currently amortize our intangible assets with finite lives over periods ranging from one to twenty years using a method that reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up or, if that pattern cannot be reliably determined, using a straight-line amortization method.
Long-lived assets, such as property and equipment and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. The recoverability of assets or asset groups to be held and used is measured by a comparison of the carrying amount of an asset or asset group to estimated undiscounted future cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset or asset group exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset or asset group exceeds the estimated fair value of the asset or asset group. Fair value is determined based on the estimated discounted future cash flows expected to be generated by the asset or asset group. Assets and liabilities to be disposed of would be separately presented in the Consolidated Balance Sheet and the assets would be reported at the lower of the carrying amount or fair value less costs to sell, and would no longer be depreciated.
Business Combination
We allocate the fair value of the purchase price of an acquisition to the tangible assets acquired, liabilities assumed, and intangible assets acquired, based on their estimated fair values. The excess of the fair value of the purchase price over the fair values of these net tangible and intangible assets acquired is recorded as goodwill. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but our estimates and assumptions are inherently uncertain and subject to refinement. The estimates and assumptions used in valuing intangible assets include, but are not limited to, the amount and timing of projected future cash flows, discount rate used to determine the present value of these cash flows and asset lives. These estimates are inherently uncertain and, therefore, actual results may differ from the estimates made. As a result, during the measurement period of up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the measurement period's conclusion or final determination of the fair value of the purchase price of an acquisition, whichever comes first, any subsequent adjustments are recorded to our Consolidated Statements of Income.
Acquisition-related expenses are recognized separately from the business combination and expensed as incurred.
Investments in Non-Affiliated Entities
Our investment in non-affiliates consists of marketable equity securities, which are publicly traded, and non-marketable equity securities, which are investments in privately held companies. Marketable equity securities have readily determinable fair values with changes in fair value recorded in other income (expense), net. Non-marketable equity securities include investments that do not have a readily determinable fair value. The investments that do not have readily determinable fair value are measured at cost minus impairment, if any, and are adjusted for changes resulting from observable price changes in orderly transactions for an identical or similar investment in the same issuer, or the measurement alternative. Fair value is based upon observable inputs in an inactive market and the valuation requires our judgment due to the absence of market prices and inherent lack of liquidity. All gains and losses on these investments, realized and unrealized, are recognized in other income (expense), net on our Consolidated Statements of Income.
We assess whether an impairment loss has occurred on our investments in non-marketable equity securities, accounted for under the measurement alternative based on quantitative and qualitative factors. If any impairment is identified for non-marketable equity securities, we write down the investment to its fair value and record the corresponding charge through other income (expense), net on our Consolidated Statements of Income.
Recently Issued Accounting Pronouncements
Recent Accounting Pronouncements Not Yet Adopted
In November 2023, the Financial Accounting Standards Board, or FASB, issued a new accounting standard to provide for additional disclosures about significant expenses in operating segments. The standard is effective for our annual reporting for fiscal year 2025 and for interim period reporting starting in fiscal year 2026 retrospectively. We are currently evaluating the impact of this standard on our Consolidated Financial Statements.
In December 2023, the FASB issued a new accounting standard which provides for new and changes to income tax disclosures including disaggregation of the rate reconciliation and income taxes paid disclosures. The amendments in the standard are effective for annual periods beginning after December 15, 2024. Early adoption is permitted and should be applied prospectively, with retrospective application permitted. We expect to adopt this standard in our annual period beginning fiscal year 2026. We are currently evaluating the impact of this standard on our Consolidated Financial Statements.
v3.24.0.1
Business Combination
12 Months Ended
Jan. 28, 2024
Business Combination and Asset Acquisition [Abstract]  
Business Combination Business Combination
Termination of the Arm Share Purchase Agreement
In February 2022, NVIDIA and SoftBank Group Corp, or SoftBank, announced the termination of the Share Purchase Agreement whereby NVIDIA would have acquired Arm from SoftBank. The parties agreed to terminate it due to significant regulatory challenges preventing the completion of the transaction. We recorded an acquisition termination cost of $1.4 billion in fiscal year 2023 reflecting the write-off of the prepayment provided at signing.
v3.24.0.1
Leases
12 Months Ended
Jan. 28, 2024
Leases [Abstract]  
Leases Leases
Our lease obligations primarily consist of operating leases for our headquarters complex, domestic and international office facilities, and data center space, with lease periods expiring between fiscal years 2025 and 2035.
Future minimum lease payments under our non-cancelable operating leases as of January 28, 2024, are as follows:
Operating Lease Obligations
 (In millions)
Fiscal Year: 
2025$290 
2026270 
2027253 
2028236 
2029202 
2030 and thereafter288 
Total1,539 
Less imputed interest192 
Present value of net future minimum lease payments1,347 
Less short-term operating lease liabilities228 
Long-term operating lease liabilities$1,119 
In addition, we have operating leases, primarily for our data centers, that are expected to commence within fiscal year 2025 with lease terms of 1 to 10 years for $1.1 billion.
Operating lease expenses for fiscal years 2024, 2023, and 2022 were $269 million, $193 million, $168 million, respectively. Short-term and variable lease expenses for fiscal years 2024, 2023, and 2022 were not significant.
Other information related to leases was as follows:
Year Ended
Jan 28, 2024Jan 29, 2023Jan 30, 2022
 (In millions)
Supplemental cash flows information 
Operating cash flows used for operating leases$286 $184 $154 
Operating lease assets obtained in exchange for lease obligations$531 $358 $266 

As of January 28, 2024, our operating leases had a weighted average remaining lease term of 6.1 years and a weighted average discount rate of 3.76%. As of January 29, 2023, our operating leases had a weighted average remaining lease term of 6.8 years and a weighted average discount rate of 3.21%.
v3.24.0.1
Stock-Based Compensation
12 Months Ended
Jan. 28, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Our stock-based compensation expense is associated with RSUs, performance stock units based on our corporate financial performance targets, or PSUs, performance stock units based on market conditions, or market-based PSUs, and our ESPP.
Our Consolidated Statements of Income include stock-based compensation expense, net of amounts allocated to inventory, as follows:
 Year Ended
Jan 28, 2024Jan 29, 2023Jan 30, 2022
 (In millions)
Cost of revenue$141 $138 $141 
Research and development2,532 1,892 1,298 
Sales, general and administrative876 680 565 
Total$3,549 $2,710 $2,004 
Stock-based compensation capitalized in inventories was not significant during fiscal years 2024, 2023, and 2022.
The following is a summary of equity awards granted under our equity incentive plans:
Year Ended
Jan 28, 2024Jan 29, 2023Jan 30, 2022
(In millions, except per share data)
RSUs, PSUs and Market-based PSUs
Awards granted14 25 18 
Estimated total grant-date fair value$5,316 $4,505 $3,492 
Weighted average grant-date fair value per share$374.08 $183.72 $190.69 
ESPP
Shares purchased
Weighted average price per share$158.07 $122.54 $56.36 
Weighted average grant-date fair value per share$69.90 $51.87 $23.24 
As of January 28, 2024, there was $8.6 billion of aggregate unearned stock-based compensation expense. This amount is expected to be recognized over a weighted average period of 2.5 years for RSUs, PSUs, and market-based PSUs, and 0.8 years for ESPP.
The fair value of shares issued under our ESPP have been estimated with the following assumptions:
 Year Ended
 Jan 28, 2024Jan 29, 2023Jan 30, 2022
(Using the Black-Scholes model)
ESPP
Weighted average expected life (in years)
0.1-2.0
0.1-2.0
0.1-2.0
Risk-free interest rate
3.9%-5.5%
—%-4.6%
—%-0.5%
Volatility
31%-67%
43%-72%
20%-58%
Dividend yield
0.1%
0.1%
0.1%
For ESPP shares, the expected term represents the average term from the first day of the offering period to the purchase date. The risk-free interest rate assumption used to value ESPP shares is based upon observed interest rates on Treasury bills appropriate for the expected term. Our expected stock price volatility assumption for ESPP is estimated using historical volatility. For awards granted, we use the dividend yield at grant date. Our RSU, PSU, and market-based PSU awards are not eligible for cash dividends prior to vesting; therefore, the fair values of RSUs, PSUs, and market-based PSUs are discounted for the dividend yield.
Additionally, for RSU, PSU, and market-based PSU awards, we estimate forfeitures semi-annually and revise the estimates of forfeiture in subsequent periods if actual forfeitures differ from those estimates. Forfeitures are estimated based on historical experience.
Equity Incentive Program
We grant or have granted stock options, RSUs, PSUs, market-based PSUs, and stock purchase rights under the following equity incentive plans. In addition, in connection with our acquisitions of various companies, we have assumed certain stock-based awards granted under their stock incentive plans and converted them into our RSUs.
Amended and Restated 2007 Equity Incentive Plan
In 2007, our shareholders approved the NVIDIA Corporation 2007 Equity Incentive Plan, or as most recently amended and restated, the 2007 Plan.
The 2007 Plan authorizes the issuance of incentive stock options, non-statutory stock options, restricted stock, RSUs, stock appreciation rights, performance stock awards, performance cash awards, and other stock-based awards to employees, directors and consultants. Only our employees may receive incentive stock options. As of January 28, 2024, up to 37 million shares of our common stock could be issued pursuant to stock awards granted under the 2007 Plan. Currently, we grant RSUs, PSUs and market-based PSUs under the 2007 Plan, under which, as of January 28, 2024, there were 147 million shares available for future grants.
Subject to certain exceptions, RSUs granted to employees vest (A) over a four-year period, subject to continued service, with 25% vesting on a pre-determined date that is close to the anniversary of the date of grant and 6.25% vesting quarterly thereafter, (B) over a three-year period, subject to continued service, with 40% vesting on a pre-determined date that is close to the anniversary of the date of grant and 7.5% vesting quarterly thereafter, or (C) over a four-year period, subject to continued service, with 6.25% vesting quarterly. PSUs vest over a four-year period, subject to continued service, with 25% vesting on a pre-determined date that is close to the anniversary of the date of grant and 6.25% vesting quarterly thereafter. Market-based PSUs vest 100% on about the three-year anniversary of the date of grant. However, the number of shares subject to both PSUs and market-based PSUs that are eligible to vest is determined by the Compensation Committee based on achievement of pre-determined criteria.
Amended and Restated 2012 Employee Stock Purchase Plan
In 2012, our shareholders approved the NVIDIA Corporation 2012 Employee Stock Purchase Plan, or as most recently amended and restated, the 2012 Plan.
Employees who participate in the 2012 Plan may have up to 15% of their earnings withheld to purchase shares of common stock. The Board may decrease this percentage at its discretion. Each offering period is about 24 months, divided into four purchase periods of six months. The price of common stock purchased under our 2012 Plan will be equal to 85% of the lower of the fair market value of the common stock on the commencement date of each offering period or the fair market value of the common stock on each purchase date within the offering. As of January 28, 2024, we had 227 million shares reserved for future issuance under the 2012 Plan.
Equity Award Activity
The following is a summary of our equity award transactions under our equity incentive plans: 
RSUs, PSUs and Market-based PSUs Outstanding
 Number of SharesWeighted Average Grant-Date Fair Value
(In millions, except per share data)
Balances, Jan 29, 202345 $158.45 
Granted14 $374.08 
Vested restricted stock(21)$148.56 
Canceled and forfeited(1)$206.35 
Balances, Jan 28, 202437 $245.94 
Vested and expected to vest after Jan 28, 202437 $245.49 

As of January 28, 2024 and January 29, 2023, there were 147 million and 160 million shares, respectively, of common stock available for future grants under our equity incentive plans. 
The total fair value of RSUs and PSUs, as of their respective vesting dates, during the years ended January 28, 2024, January 29, 2023, and January 30, 2022, was $8.2 billion, $4.3 billion, and $5.6 billion, respectively.
v3.24.0.1
Net Income Per Share
12 Months Ended
Jan. 28, 2024
Earnings Per Share [Abstract]  
Net Income Per Share Net Income Per Share
The following is a reconciliation of the denominator of the basic and diluted net income per share computations for the periods presented:
 Year Ended
 Jan 28, 2024Jan 29, 2023Jan 30, 2022
 (In millions, except per share data)
Numerator:   
Net income$29,760 $4,368 $9,752 
Denominator:   
Basic weighted average shares2,469 2,487 2,496 
Dilutive impact of outstanding equity awards25 20 39 
Diluted weighted average shares2,494 2,507 2,535 
Net income per share:   
Basic (1)$12.05 $1.76 $3.91 
Diluted (2)$11.93 $1.74 $3.85 
Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive
15 40 21 
(1)    Calculated as net income divided by basic weighted average shares.
(2)    Calculated as net income divided by diluted weighted average shares.
v3.24.0.1
Goodwill
12 Months Ended
Jan. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill GoodwillAs of January 28, 2024, the total carrying amount of goodwill was $4.4 billion, consisting of goodwill balances allocated to our Compute & Networking and Graphics reporting units of $4.1 billion and $370 million, respectively. As of January 29, 2023, the total carrying amount of goodwill was $4.4 billion, consisting of goodwill balances allocated to our Compute & Networking and Graphics reporting units of $4.0 billion and $370 million, respectively. Goodwill increased by $59 million in fiscal year 2024 from an immaterial acquisition and was allocated to our Compute & Networking reporting unit. During the fourth quarters of fiscal years 2024, 2023, and 2022, we completed our annual qualitative impairment tests and concluded that goodwill was not impaired.
v3.24.0.1
Amortizable Intangible Assets
12 Months Ended
Jan. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Amortizable Intangible Assets Amortizable Intangible Assets
The components of our amortizable intangible assets are as follows:
 Jan 28, 2024Jan 29, 2023
 
Gross
Carrying
Amount
Accumulated
Amortization
Net 
Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net 
Carrying
Amount
 (In millions)
Acquisition-related intangible assets (1)$2,642 $(1,720)$922 $3,093 $(1,614)$1,479 
Patents and licensed technology449 (259)190 446 (249)197 
Total intangible assets$3,091 $(1,979)$1,112 $3,539 $(1,863)$1,676 
(1)    During the first quarter of fiscal year 2023, we commenced amortization of a $630 million in-process research and development intangible asset related to our acquisition of Mellanox.
Amortization expense associated with intangible assets for fiscal years 2024, 2023, and 2022 was $614 million, $699 million, and $563 million, respectively.
The following table outlines the estimated future amortization expense related to the net carrying amount of intangible assets as of January 28, 2024:
Future Amortization Expense
 (In millions)
Fiscal Year: 
2025$555 
2026261 
2027150 
202837 
2029
2030 and thereafter100 
Total$1,112 
v3.24.0.1
Cash Equivalents and Marketable Securities
12 Months Ended
Jan. 28, 2024
Investments, Debt and Equity Securities [Abstract]  
Cash Equivalents and Marketable Securities Cash Equivalents and Marketable Securities
Our cash equivalents and marketable securities related to debt securities are classified as “available-for-sale” debt securities.
The following is a summary of cash equivalents and marketable securities:

 Jan 28, 2024
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value
Reported as
 Cash EquivalentsMarketable Securities
 (In millions)
Corporate debt securities$10,126 $31 $(5)$10,152 $2,231 $7,921 
Debt securities issued by the U.S. Treasury9,517 17 (10)9,524 1,315 8,209 
Debt securities issued by U.S. government agencies2,326 (1)2,333 89 2,244 
Money market funds3,031 — — 3,031 3,031 — 
Certificates of deposit510 — — 510 294 216 
Foreign government bonds174 — — 174 60 114 
Total$25,684 $56 $(16)$25,724 $7,020 $18,704 

 Jan 29, 2023
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value
Reported as
 Cash EquivalentsMarketable Securities
 (In millions)
Corporate debt securities$4,809 $— $(12)$4,797 $1,087 $3,710 
Debt securities issued by the U.S. Treasury4,185 (44)4,142 — 4,142 
Debt securities issued by U.S. government agencies1,836 — (2)1,834 50 1,784 
Money market funds1,777 — — 1,777 1,777 — 
Certificates of deposit365 — — 365 134 231 
Foreign government bonds140 — — 140 100 40 
Total$13,112 $$(58)$13,055 $3,148 $9,907 
The following tables provide the breakdown of unrealized losses, aggregated by investment category and length of time that individual securities have been in a continuous loss position:
Jan 28, 2024
 Less than 12 Months12 Months or GreaterTotal
 Estimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized Loss
 (In millions)
Debt securities issued by the U.S. Treasury$3,343 $(5)$1,078 $(5)$4,421 $(10)
Corporate debt securities1,306 (3)618 (2)1,924 (5)
Debt securities issued by U.S. government agencies670 (1)— — 670 (1)
Total$5,319 $(9)$1,696 $(7)$7,015 $(16)
Jan 29, 2023
 Less than 12 Months12 Months or GreaterTotal
 Estimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized Loss
 (In millions)
Debt securities issued by the U.S. Treasury$2,444 $(21)$1,172 $(23)$3,616 $(44)
Corporate debt securities1,188 (7)696 (5)1,884 (12)
Debt securities issued by U.S. government agencies1,307 (2)— — 1,307 (2)
Total$4,939 $(30)$1,868 $(28)$6,807 $(58)
The gross unrealized losses are related to fixed income securities, driven primarily by changes in interest rates. Net realized gains and losses were not significant for all periods presented.
The amortized cost and estimated fair value of cash equivalents and marketable securities are shown below by contractual maturity.
 Jan 28, 2024Jan 29, 2023
 Amortized
Cost
Estimated
Fair Value
Amortized
Cost
Estimated
Fair Value
 (In millions)
Less than one year$16,336 $16,329 $9,738 $9,708 
Due in 1 - 5 years9,348 9,395 3,374 3,347 
Total$25,684 $25,724 $13,112 $13,055 
v3.24.0.1
Fair Value of Financial Assets and Liabilities and Investments in Non-Affiliated Entities
12 Months Ended
Jan. 28, 2024
Fair Value Disclosures [Abstract]  
Fair Value of Financial Assets and Liabilities and Investments in Non-Affiliated Entities Fair Value of Financial Assets and Liabilities and Investments in Non-Affiliated Entities
The fair values of our financial assets and liabilities are determined using quoted market prices of identical assets or quoted market prices of similar assets from active markets. We review fair value hierarchy classification on a quarterly basis.
Fair Value at
Pricing CategoryJan 28, 2024Jan 29, 2023
(In millions)
Assets
Cash equivalents and marketable securities:
Money market fundsLevel 1$3,031 $1,777 
Corporate debt securitiesLevel 2$10,152 $4,797 
Debt securities issued by the U.S. TreasuryLevel 2$9,524 $4,142 
Debt securities issued by U.S. government agenciesLevel 2$2,333 $1,834 
Certificates of depositLevel 2$510 $365 
Foreign government bondsLevel 2$174 $140 
Other assets (Investment in non-affiliated entities):
Publicly-held equity securitiesLevel 1$225 $11 
Liabilities (1)
0.309% Notes Due 2023
Level 2$— $1,230 
0.584% Notes Due 2024
Level 2$1,228 $1,185 
3.20% Notes Due 2026
Level 2$970 $966 
1.55% Notes Due 2028
Level 2$1,115 $1,099 
2.85% Notes Due 2030
Level 2$1,367 $1,364 
2.00% Notes Due 2031
Level 2$1,057 $1,044 
3.50% Notes Due 2040
Level 2$851 $870 
3.50% Notes Due 2050
Level 2$1,604 $1,637 
3.70% Notes Due 2060
Level 2$403 $410 
(1)    These liabilities are carried on our Consolidated Balance Sheets at their original issuance value, net of unamortized debt discount and issuance costs.
Investments in Non-Affiliated Entities
Our investments in non-affiliated entities include marketable equity securities, which are publicly traded, and non-marketable equity securities, which are primarily investments in privately held companies. Our marketable equity securities have readily determinable fair values and are recorded as long-term other assets on our Consolidated Balance Sheets at fair value with changes in fair value recorded in Other income and expense, net on our Consolidated Statements of Income. Marketable equity securities totaled $225 million and $11 million as of January 28, 2024 and January 29, 2023, respectively. The net unrealized and realized gains and losses of investments in marketable securities net were not significant for fiscal years 2024, 2023 and 2022.
Our non-marketable equity securities are recorded in long-term other assets on our Consolidated Balance Sheets. The carrying value of our non-marketable equity securities totaled $1.3 billion and $288 million as of January 28, 2024 and January 29, 2023, respectively. Gains and losses on these investments, realized and unrealized, are recognized in Other income and expense, net on our Consolidated Statements of Income.
Adjustments to the carrying value of our non-marketable equity securities accounted for under the measurement alternative were as follows:
Year Ended
Jan 28, 2024
(In millions)
Carrying amount as of Jan 29, 2023$288 
Adjustments related to non-marketable equity securities:
Net additions859 
Unrealized gains194 
Impairments and unrealized losses(20)
Carrying amount as of Jan 28, 2024$1,321 

In the fourth quarter of fiscal year 2024, one of our private company investments completed a secondary equity raise that resulted in an unrealized gain of $178 million.
Net unrealized gains recognized for the year ended January 28, 2024 for non-marketable investments in non-affiliated entities still held as of January 28, 2024 were $174 million. Net unrealized and realized gains related to non-marketable equity securities were not significant for fiscal years 2023 and 2022.
The following table summarizes the cumulative gross unrealized gains and cumulative gross unrealized losses and impairments related to non-marketable equity securities accounted for under the measurement alternative:
Jan 28, 2024
(In millions)
Cumulative gross unrealized gains$270 
Cumulative gross unrealized losses and impairments(45)
v3.24.0.1
Balance Sheet Components
12 Months Ended
Jan. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components Balance Sheet Components
Two customers accounted for 24% and 11% of our accounts receivable balance as of January 28, 2024. Two customers accounted for 14% and 11% of our accounts receivable balance as of January 29, 2023.
Certain balance sheet components are as follows:
 Jan 28, 2024Jan 29, 2023
(In millions)
Inventories (1):
Raw materials$1,719 $2,430 
Work in-process1,505 466 
Finished goods2,058 2,263 
Total inventories$5,282 $5,159 
(1) In fiscal years 2024 and 2023, we recorded an inventory provision of $774 million and $1.0 billion, respectively, in cost of revenue.
 Jan 28, 2024Jan 29, 2023Estimated
Useful Life
(In millions)(In years)
Property and Equipment:
Land$218 $218 (A)
Buildings, leasehold improvements, and furniture1,816 1,598 (B)
Equipment, compute hardware, and software5,200 4,303 
3-7
Construction in process189 382 (C)
Total property and equipment, gross7,423 6,501  
Accumulated depreciation and amortization(3,509)(2,694) 
Total property and equipment, net$3,914 $3,807  
(A)Land is a non-depreciable asset.
(B)The estimated useful lives of our buildings are up to thirty years. Leasehold improvements and finance leases are amortized based on the lesser of either the asset’s estimated useful life or the expected remaining lease term.
(C)Construction in process represents assets that are not available for their intended use as of the balance sheet date.
Depreciation expense for fiscal years 2024, 2023, and 2022 was $894 million, $844 million, and $611 million, respectively.
Accumulated amortization of leasehold improvements and finance leases was $400 million and $327 million as of January 28, 2024 and January 29, 2023, respectively.
Property, equipment and intangible assets acquired by assuming related liabilities during fiscal years 2024, 2023, and 2022 were $170 million, $374 million, and $258 million, respectively.
 Jan 28, 2024Jan 29, 2023
Other assets:(In millions)
Prepaid supply and capacity agreements (1)$2,458 $2,989 
Investments in non-affiliated entities1,546 299 
Prepaid royalties364 387 
Other132 145 
Total other assets$4,500 $3,820 
(1)As of January 28, 2024 and January 29, 2023, there was an additional $2.5 billion and $458 million of short-term prepaid supply and capacity agreements included in Prepaid expenses and other current assets, respectively.
 Jan 28, 2024Jan 29, 2023
(In millions)
Accrued and Other Current Liabilities:
Customer program accruals$2,081 $1,196 
Excess inventory purchase obligations (1)1,655 954 
Deferred revenue (2)764 354 
Accrued payroll and related expenses675 530 
Product warranty and return provisions415 108 
Taxes payable296 467 
Operating leases228 176 
Unsettled share repurchases187 117 
Licenses and royalties182 149 
Other199 69 
Total accrued and other current liabilities$6,682 $4,120 
(1)In fiscal years 2024 and 2023, we recorded an expense of approximately $1.4 billion and $1.1 billion, respectively, in cost of revenue for inventory purchase obligations in excess of our current demand projections, supplier charges and for penalties related to cancellations and underutilization.
(2)Deferred revenue primarily includes customer advances and deferrals related to support for hardware and software, license and development arrangements, and cloud services. $233 million and $35 million of the balance in fiscal 2024 and 2023 respectively, related to customer advances.
 Jan 28, 2024Jan 29, 2023
(In millions)
Other Long-Term Liabilities:
Income tax payable (1)$1,361 $1,204 
Deferred income tax462 247 
Deferred revenue (2)573 218 
Licenses payable80 181 
Other65 63 
Total other long-term liabilities$2,541 $1,913 
(1)Income tax payable is comprised of the long-term portion of the one-time transition tax payable, unrecognized tax benefits, and related interest and penalties.
(2)Deferred revenue primarily includes deferrals related to support for hardware and software.
Deferred Revenue
The following table shows the changes in deferred revenue during fiscal years 2024 and 2023.
 Jan 28, 2024Jan 29, 2023
(In millions)
Balance at beginning of period$572 $502 
Deferred revenue additions during the period2,038 830 
Revenue recognized during the period(1,273)(760)
Balance at end of period$1,337 $572 
Revenue recognized during fiscal year 2024 that was included in deferred revenue as of January 29, 2023 was $338 million. Revenue recognized during fiscal year 2023 that was included in deferred revenue as of January 30, 2022 was $282 million.
Revenue related to remaining performance obligations represents the contracted license and development arrangements and support for hardware and software. This includes deferred revenue currently recorded and amounts that will be
invoiced in future periods. Revenue allocated to remaining performance obligations, which includes deferred revenue and amounts that will be invoiced and recognized as revenue in future periods, was $1.1 billion as of January 28, 2024. We expect to recognize approximately 40% of this revenue over the next twelve months and the remainder thereafter. This excludes revenue related to performance obligations for contracts with a length of one year or less.
v3.24.0.1
Derivative Financial Instruments
12 Months Ended
Jan. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
We enter into foreign currency forward contracts to mitigate the impact of foreign currency exchange rate movements on our operating expenses. These contracts are designated as cash flow hedges for hedge accounting treatment. Gains or losses on the contracts are recorded in accumulated other comprehensive income or loss and reclassified to operating expense when the related operating expenses are recognized in earnings or ineffectiveness should occur.
We also enter into foreign currency forward contracts to mitigate the impact of foreign currency movements on monetary assets and liabilities that are denominated in currencies other than the U.S. dollar. These forward contracts were not designated for hedge accounting treatment. Therefore, the change in fair value of these contracts is recorded in other income or expense and offsets the change in fair value of the hedged foreign currency denominated monetary assets and liabilities, which is also recorded in other income or expense.
The table below presents the notional value of our foreign currency forward contracts outstanding:

Jan 28, 2024Jan 29, 2023
 (In millions)
Designated as cash flow hedges$1,168 $1,128 
Non-designated hedges$597 $366 
The unrealized gains and losses or fair value of our foreign currency forward contracts was not significant as of January 28, 2024 and January 29, 2023.
As of January 28, 2024, all designated foreign currency forward contracts mature within 18 months. The expected realized gains and losses deferred into accumulated other comprehensive income or loss related to foreign currency forward contracts within the next twelve months was not significant.
During fiscal years 2024 and 2023, the impact of derivative financial instruments designated for hedge accounting treatment on other comprehensive income or loss was not significant and all such instruments were determined to be highly effective.
v3.24.0.1
Debt
12 Months Ended
Jan. 28, 2024
Debt Disclosure [Abstract]  
Debt Debt
Long-Term Debt
The carrying value of our outstanding notes, the calendar year of maturity, and the associated interest rates were as follows:
 Expected
Remaining Term (years)
Effective
Interest Rate
Jan 28, 2024Jan 29, 2023
   (In millions)
0.309% Notes Due 2023 (1)
0.41%$— $1,250 
0.584% Notes Due 2024
0.40.66%1,250 1,250 
3.20% Notes Due 2026
2.63.31%1,000 1,000 
1.55% Notes Due 2028
4.41.64%1,250 1,250 
2.85% Notes Due 2030
6.22.93%1,500 1,500 
2.00% Notes Due 2031
7.42.09%1,250 1,250 
3.50% Notes Due 2040
16.23.54%1,000 1,000 
3.50% Notes Due 2050
26.23.54%2,000 2,000 
3.70% Notes Due 2060
36.23.73%500 500 
Unamortized debt discount and issuance costs  (41)(47)
Net carrying amount  9,709 10,953 
Less short-term portion(1,250)(1,250)
Total long-term portion$8,459 $9,703 
(1) In fiscal year 2024, we repaid the 0.309% Notes Due 2023.
All our notes are unsecured senior obligations. All existing and future liabilities of our subsidiaries will be effectively senior to the notes. Our notes pay interest semi-annually. We may redeem each of our notes prior to maturity, subject to a make-whole premium as defined in the applicable form of note.
As of January 28, 2024, we were in compliance with the required covenants, which are non-financial in nature, under the outstanding notes.
Commercial Paper
We have a $575 million commercial paper program to support general corporate purposes. As of January 28, 2024, we had no commercial paper outstanding.
v3.24.0.1
Commitments and Contingencies
12 Months Ended
Jan. 28, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Purchase Obligations
Our purchase obligations reflect our commitments to purchase components used to manufacture our products, including long-term supply and capacity agreements, certain software and technology licenses, other goods and services and long-lived assets.
As of January 28, 2024, we had outstanding inventory purchase and long-term supply and capacity obligations totaling $16.1 billion. We enter into agreements with contract manufacturers that allow them to procure inventory based upon criteria as defined by us, and in certain instances, these agreements allow us the option to cancel, reschedule, and adjust our requirements based on our business needs prior to firm orders being placed, but these changes may result in the payment of costs incurred through the date of cancellation. Other non-inventory purchase obligations were $4.6 billion, which includes $3.5 billion of multi-year cloud service agreements, primarily to support our research and development efforts.
Total future purchase commitments as of January 28, 2024 are as follows:
Commitments
 (In millions)
Fiscal Year: 
2025$17,316 
20261,143 
20271,060 
2028770 
2029 and thereafter418 
Total$20,707 
Accrual for Product Warranty Liabilities
The estimated amount of product warranty liabilities was $306 million and $82 million as of January 28, 2024 and January 29, 2023, respectively. The estimated product returns and estimated product warranty activity consisted of the following:
Year Ended
Jan 28, 2024Jan 29, 2023Jan 30, 2022
(In millions)
Balance at beginning of period$82 $46 $22 
Additions278 14540
Utilization(54)(109)(16)
Balance at end of period$306 $82 $46 
In fiscal years 2024 and 2023, the additions in product warranty liabilities primarily related to Compute & Networking segment.
We have provided indemnities for matters such as tax, product, and employee liabilities. We have included intellectual property indemnification provisions in our technology-related agreements with third parties. Maximum potential future payments cannot be estimated because many of these agreements do not have a maximum stated liability. We have not recorded any liability in our Consolidated Financial Statements for such indemnifications.
Litigation
Securities Class Action and Derivative Lawsuits
The plaintiffs in the putative securities class action lawsuit, captioned 4:18-cv-07669-HSG, initially filed on December 21, 2018 in the United States District Court for the Northern District of California, and titled In Re NVIDIA Corporation Securities Litigation, filed an amended complaint on May 13, 2020. The amended complaint asserted that NVIDIA and certain NVIDIA executives violated Section 10(b) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and SEC Rule 10b-5, by making materially false or misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand between May 10, 2017 and November 14, 2018. Plaintiffs also alleged that the NVIDIA executives who they named as defendants violated Section 20(a) of the Exchange Act. Plaintiffs sought class certification, an award of unspecified compensatory damages, an award of reasonable costs and expenses, including attorneys’ fees and expert fees, and further relief as the Court may deem just and proper. On March 2, 2021, the district court granted NVIDIA’s motion to dismiss the complaint without leave to amend, entered judgment in favor of NVIDIA and closed the case. On March 30, 2021, plaintiffs filed an appeal from judgment in the United States Court of Appeals for the Ninth Circuit, case number 21-15604. On August 25, 2023, a majority of a three-judge Ninth Circuit panel affirmed in part and reversed in part the district court’s dismissal of the case, with a third judge dissenting on the basis that the district court did not err in dismissing the case. On November 15, 2023, the Ninth Circuit denied NVIDIA’s petition for rehearing en banc of the Ninth Circuit panel’s majority decision to reverse in part the dismissal of the case, which NVIDIA had filed on October 10, 2023. On November 21, 2023, NVIDIA filed a motion with the Ninth Circuit for a stay of the mandate pending NVIDIA’s petition for a writ of certiorari in the Supreme Court of the United States and the Supreme Court’s
resolution of the matter. On December 5, 2023, the Ninth Circuit granted NVIDIA’s motion to stay the mandate. NVIDIA’s deadline to file a petition for a writ of certiorari is March 4, 2024.
The putative derivative lawsuit pending in the United States District Court for the Northern District of California, captioned 4:19-cv-00341-HSG, initially filed January 18, 2019 and titled In re NVIDIA Corporation Consolidated Derivative Litigation, was stayed pending resolution of the plaintiffs’ appeal in the In Re NVIDIA Corporation Securities Litigation action. On February 22, 2022, the court administratively closed the case, but stated that it would reopen the case once the appeal in the In Re NVIDIA Corporation Securities Litigation action is resolved. Following the Ninth Circuit’s denial of NVIDIA’s petition for rehearing on November 15, 2023, the parties are conferring regarding the next steps in this derivative matter. The lawsuit asserts claims, purportedly on behalf of us, against certain officers and directors of the Company for breach of fiduciary duty, unjust enrichment, waste of corporate assets, and violations of Sections 14(a), 10(b), and 20(a) of the Exchange Act based on the dissemination of allegedly false and misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand. The plaintiffs are seeking unspecified damages and other relief, including reforms and improvements to NVIDIA’s corporate governance and internal procedures.
The putative derivative actions initially filed September 24, 2019 and pending in the United States District Court for the District of Delaware, Lipchitz v. Huang, et al. (Case No. 1:19-cv-01795-UNA) and Nelson v. Huang, et. al. (Case No. 1:19-cv-01798- UNA), remain stayed pending resolution of the plaintiffs’ appeal in the In Re NVIDIA Corporation Securities Litigation action. Following the Ninth Circuit’s denial of NVIDIA’s petition for rehearing on November 15, 2023, the parties are conferring regarding the next steps in these derivative matters. The lawsuits assert claims, purportedly on behalf of us, against certain officers and directors of the Company for breach of fiduciary duty, unjust enrichment, insider trading, misappropriation of information, corporate waste and violations of Sections 14(a), 10(b), and 20(a) of the Exchange Act based on the dissemination of allegedly false, and misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand. The plaintiffs seek unspecified damages and other relief, including disgorgement of profits from the sale of NVIDIA stock and unspecified corporate governance measures.
Another putative derivative action was filed on October 30, 2023 in the Court of Chancery of the State of Delaware, captioned Horanic v. Huang, et al. (Case No. 2023-1096-KSJM). This lawsuit asserts claims, purportedly on behalf of us, against certain officers and directors of the Company for breach of fiduciary duty and insider trading based on the dissemination of allegedly false and misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand. The plaintiffs seek unspecified damages and other relief, including disgorgement of profits from the sale of NVIDIA stock and reform of unspecified corporate governance measures. This derivative matter is stayed pending the final resolution of In Re NVIDIA Corporation Securities Litigation action.
Accounting for Loss Contingencies
As of January 28, 2024, we have not recorded any accrual for contingent liabilities associated with the legal proceedings described above based on our belief that liabilities, while possible, are not probable. Further, except as specifically described above, any possible loss or range of loss in these matters cannot be reasonably estimated at this time. We are engaged in legal actions not described above arising in the ordinary course of business and, while there can be no assurance of favorable outcomes, we believe that the ultimate outcome of these actions will not have a material adverse effect on our operating results, liquidity or financial position.
v3.24.0.1
Income Taxes
12 Months Ended
Jan. 28, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The income tax expense (benefit) applicable to income before income taxes consists of the following:
 Year Ended
 Jan 28, 2024Jan 29, 2023Jan 30, 2022
 (In millions)
Current income taxes:   
Federal$5,710 $1,703 $482 
State335 46 42 
Foreign502 228 71 
Total current6,547 1,977 595 
Deferred income taxes:   
Federal(2,499)(2,165)(420)
State(206)— — 
Foreign216 14 
Total deferred(2,489)(2,164)(406)
Income tax expense (benefit)$4,058 $(187)$189 
Income before income tax consists of the following:
 Year Ended
 Jan 28, 2024Jan 29, 2023Jan 30, 2022
 (In millions)
U.S.$29,495 $3,477 $8,446 
Foreign4,323 704 1,495 
Income before income tax$33,818 $4,181 $9,941 
The income tax expense (benefit) differs from the amount computed by applying the U.S. federal statutory rate of 21% to income before income taxes as follows:
 Year Ended
 Jan 28, 2024Jan 29, 2023Jan 30, 2022
 (In millions, except percentages)
Tax expense computed at federal statutory rate$7,102 21.0 %$878 21.0 %$2,088 21.0 %
Expense (benefit) resulting from:
State income taxes, net of federal tax effect120 0.4 %50 1.2 %42 0.4 %
Foreign-derived intangible income(1,408)(4.2)%(739)(17.7)%(520)(5.2)%
Stock-based compensation(741)(2.2)%(309)(7.4)%(337)(3.4)%
Foreign tax rate differential(467)(1.4)%(83)(2.0)%(497)(5.0)%
U.S. federal research and development tax credit(431)(1.3)%(278)(6.6)%(289)(2.9)%
Acquisition termination cost— — %261 6.2 %— — %
IP domestication— — %— — %(244)(2.5)%
Other(117)(0.3)%33 0.8 %(54)(0.5)%
Income tax expense (benefit)$4,058 12.0 %$(187)(4.5)%$189 1.9 %
The tax effect of temporary differences that gives rise to significant portions of the deferred tax assets and liabilities are presented below:
 Jan 28, 2024Jan 29, 2023
 (In millions)
Deferred tax assets: 
Capitalized research and development expenditure$3,376 $1,859 
GILTI deferred tax assets1,576 800 
Accruals and reserves, not currently deductible for tax purposes1,121 686 
Research and other tax credit carryforwards936 951 
Net operating loss and capital loss carryforwards439 409 
Operating lease liabilities263 193 
Stock-based compensation106 99 
Property, equipment and intangible assets66 
Other deferred tax assets179 91 
Gross deferred tax assets8,000 5,154 
Less valuation allowance(1,552)(1,484)
Total deferred tax assets6,448 3,670 
Deferred tax liabilities:  
Unremitted earnings of foreign subsidiaries(502)(228)
Operating lease assets(255)(179)
Acquired intangibles(74)(115)
Gross deferred tax liabilities(831)(522)
Net deferred tax asset (1)$5,617 $3,148 
(1) Net deferred tax asset includes long-term deferred tax assets of $6.1 billion and $3.4 billion and long-term deferred tax liabilities of $462 million and $247 million for fiscal years 2024 and 2023, respectively. Long-term deferred tax liabilities are included in other long-term liabilities on our Consolidated Balance Sheets.
As of January 28, 2024, we intend to indefinitely reinvest approximately $1.1 billion and $250 million of cumulative undistributed earnings held by certain subsidiaries in Israel and the United Kingdom, respectively. We have not provided the amount of unrecognized deferred tax liabilities for temporary differences related to these investments as the determination of such amount is not practicable.
As of January 28, 2024 and January 29, 2023, we had a valuation allowance of $1.6 billion and $1.5 billion, respectively, related to capital loss carryforwards, and certain state and other deferred tax assets that management determined are not likely to be realized due, in part, to jurisdictional projections of future taxable income, including capital gains. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax assets as income tax benefits during the period.
As of January 28, 2024, we had U.S. federal, state and foreign net operating loss carryforwards of $315 million, $342 million and $361 million, respectively. The federal and state carryforwards will begin to expire in fiscal years 2026 and 2025, respectively. The foreign net operating loss carryforwards of $361 million may be carried forward indefinitely. As of January 28, 2024, we had federal research tax credit carryforwards of $31 million, before the impact of uncertain tax positions, that will begin to expire in fiscal year 2025. We have state research tax credit carryforwards of $1.6 billion, before the impact of uncertain tax positions. $1.5 billion is attributable to the State of California and may be carried over indefinitely and $75 million is attributable to various other states and will begin to expire in fiscal year 2025. As of January 28, 2024, we had federal capital loss carryforwards of $1.4 billion that will begin to expire in fiscal year 2025.
Our tax attributes remain subject to audit and may be adjusted for changes or modification in tax laws, other authoritative interpretations thereof, or other facts and circumstances. Utilization of tax attributes may also be subject to limitations due to ownership changes and other limitations provided by the Internal Revenue Code and similar state and foreign tax provisions. If any such limitations apply, the tax attributes may expire or be denied before utilization.
A reconciliation of gross unrecognized tax benefits is as follows:
 Jan 28, 2024Jan 29, 2023Jan 30, 2022
 (In millions)
Balance at beginning of period$1,238 $1,013 $776 
Increases in tax positions for current year616 268 246 
Increases in tax positions for prior years87 14 
Decreases in tax positions for prior years(148)(15)(4)
Settlements(104)(9)(8)
Lapse in statute of limitations(19)(20)(11)
Balance at end of period$1,670 $1,238 $1,013 
Included in the balance of unrecognized tax benefits as of January 28, 2024 are $1.0 billion of tax benefits that would affect our effective tax rate if recognized.
We classify an unrecognized tax benefit as a current liability, or amount refundable, to the extent that we anticipate payment or receipt of cash for income taxes within one year. The amount is classified as a long-term liability, or reduction of long-term amount refundable, if we anticipate payment or receipt of cash for income taxes during a period beyond a year.
We include interest and penalties related to unrecognized tax benefits as a component of income tax expense. We recognized net interest and penalties related to unrecognized tax benefits in the income tax expense line of our consolidated statements of income of $42 million, $33 million, and $14 million during fiscal years 2024, 2023 and 2022, respectively. As of January 28, 2024 and January 29, 2023, we have accrued $140 million and $95 million, respectively, for the payment of interest and penalties related to unrecognized tax benefits, which is not included as a component of our gross unrecognized tax benefits.
While we believe that we have adequately provided for all tax positions, amounts asserted by tax authorities could be greater or less than our accrued position. Accordingly, our provisions on federal, state and foreign tax-related matters to be recorded in the future may change as revised estimates are made or the underlying matters are settled or otherwise resolved. As of January 28, 2024, we have not identified any positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease within the next twelve months.
We are subject to taxation by taxing authorities both in the United States and other countries. As of January 28, 2024, the significant tax jurisdictions that may be subject to examination include the United States for fiscal years after 2020, as well as China, Germany, Hong Kong, India, Israel, Taiwan, and the United Kingdom for fiscal years 2005 through 2023. As of January 28, 2024, the significant tax jurisdictions for which we are currently under examination include Germany, India, Israel, and Taiwan for fiscal years 2005 through 2023.
v3.24.0.1
Shareholders’ Equity
12 Months Ended
Jan. 28, 2024
Equity [Abstract]  
Shareholders’ Equity Shareholders’ Equity
Capital Return Program
In August 2023, our Board of Directors approved an increase to our share repurchase program of an additional $25.0 billion, without expiration. During fiscal year 2024, we repurchased 21 million shares of our common stock for $9.7 billion. As of January 28, 2024, we were authorized, subject to certain specifications, to repurchase additional shares of our common stock up to $22.5 billion. From January 29, 2024 through February 16, 2024, we repurchased 2.8 million shares for $1.9 billion pursuant to a Rule 10b5-1 trading plan. Our share repurchase program aims to offset dilution from shares issued to employees. We may pursue additional share repurchases as we weigh market factors and other investment opportunities.
During fiscal years 2024, 2023, and 2022, we paid $395 million, $398 million, and $399 million in cash dividends to our shareholders, respectively. Our cash dividend program and the payment of future cash dividends under that program are subject to our Board of Directors' continuing determination that the dividend program and the declaration of dividends thereunder are in the best interests of our shareholders.
In fiscal year 2022, we retired our existing 349 million treasury shares. These shares assumed the status of authorized and unissued shares upon retirement. The excess of repurchase price over par value was allocated between additional paid-in capital and retained earnings, resulting in a reduction in additional paid-in capital by $20 million and retained earnings by $12.0 billion. Any future repurchased shares will assume the status of authorized and unissued shares.
v3.24.0.1
Employee Retirement Plans
12 Months Ended
Jan. 28, 2024
Retirement Benefits [Abstract]  
Employee Retirement Plans Employee Retirement Plans
We provide tax-qualified defined contribution plans to eligible employees in the U.S. and certain other countries. Our contribution expense for fiscal years 2024, 2023, and 2022 was $255 million, $227 million, and $168 million, respectively.
v3.24.0.1
Segment Information
12 Months Ended
Jan. 28, 2024
Segment Reporting [Abstract]  
Segment Information Segment Information 
Our Chief Executive Officer, who is considered to be our chief operating decision maker, or CODM, reviews financial information presented on an operating segment basis for purposes of making decisions and assessing financial performance.
The Compute & Networking segment includes our Data Center accelerated computing platform; networking; automotive artificial intelligence, or AI, Cockpit, autonomous driving development agreements, and autonomous vehicle solutions; electric vehicle computing platforms; Jetson for robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud.
The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse Enterprise software for building and operating 3D internet applications.
Operating results by segment include costs or expenses that are directly attributable to each segment, and costs or expenses that are leveraged across our unified architecture and therefore allocated between our two segments.
The “All Other” category includes the expenses that our CODM does not assign to either Compute & Networking or Graphics for purposes of making operating decisions or assessing financial performance. The expenses include stock-based compensation expense, corporate infrastructure and support costs, acquisition-related and other costs, intellectual property related, or IP-related costs, acquisition termination cost, and other non-recurring charges and benefits that our CODM deems to be enterprise in nature.
Our CODM does not review any information regarding total assets on a reportable segment basis. Depreciation and amortization expense directly attributable to each reportable segment is included in operating results for each segment. However, our CODM does not evaluate depreciation and amortization expense by operating segment and, therefore, it is not separately presented. There is no intersegment revenue. The accounting policies for segment reporting are the same as for our consolidated financial statements. The table below presents details of our reportable segments and the “All Other” category.
 Compute & NetworkingGraphicsAll OtherConsolidated
(In millions)
Year Ended Jan 28, 2024:
   
Revenue$47,405 $13,517 $— $60,922 
Operating income (loss)$32,016 $5,846 $(4,890)$32,972 
Year Ended Jan 29, 2023:
   
Revenue$15,068 $11,906 $— $26,974 
Operating income (loss)$5,083 $4,552 $(5,411)$4,224 
Year Ended Jan 30, 2022:
   
Revenue$11,046 $15,868 $— $26,914 
Operating income (loss)$4,598 $8,492 $(3,049)$10,041 
Year Ended
Jan 28, 2024Jan 29, 2023Jan 30, 2022
(In millions)
Reconciling items included in "All Other" category:
Stock-based compensation expense$(3,549)$(2,710)$(2,004)
Unallocated cost of revenue and operating expenses(728)(595)(399)
Acquisition-related and other costs(583)(674)(636)
IP-related and legal settlement costs(40)(23)(10)
Restructuring costs and other— (54)— 
Acquisition termination cost— (1,353)— 
Other10 (2)— 
Total$(4,890)$(5,411)$(3,049)
Revenue by geographic areas is designated based upon the billing location of the customer. End customer location may be different than our customer’s billing location. Revenue by geographic areas was as follows: 
 Year Ended
 Jan 28, 2024Jan 29, 2023Jan 30, 2022
Revenue:(In millions)
United States$26,966 $8,292 $4,349 
Taiwan13,405 6,986 8,544 
China (including Hong Kong)10,306 5,785 7,111 
Other countries10,245 5,911 6,910 
Total revenue$60,922 $26,974 $26,914 
Revenue from sales to customers outside of the United States accounted for 56%, 69%, and 84% of total revenue for fiscal years 2024, 2023, and 2022, respectively. The increase in revenue to the United States for fiscal year 2024 was primarily due to higher U.S.-based Compute & Networking segment demand.
Sales to one customer represented 13% of total revenue for fiscal year 2024, which was attributable to the Compute & Networking segment. No customer represented 10% or more of total revenue for fiscal years 2023 and 2022.
The following table summarizes information pertaining to our revenue by each of the specialized markets we serve:
 Year Ended
 Jan 28, 2024Jan 29, 2023Jan 30, 2022
Revenue:(In millions)
Data Center$47,525 $15,005 $10,613 
Gaming10,447 9,067 12,462 
Professional Visualization1,553 1,544 2,111 
Automotive1,091 903 566 
OEM and Other306 455 1,162 
Total revenue$60,922 $26,974 $26,914 
The following table presents summarized information for long-lived assets by country. Long-lived assets consist of property and equipment and exclude other assets, operating lease assets, goodwill, and intangible assets.
 Jan 28, 2024Jan 29, 2023
Long-lived assets:(In millions)
United States$2,595 $2,587 
Taiwan773 702 
Israel325 283 
Other countries221 235 
Total long-lived assets$3,914 $3,807 
v3.24.0.1
Schedule II - Valuation and Qualifying Accounts
12 Months Ended
Jan. 28, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II - Valuation and Qualifying Accounts
Schedule II – Valuation and Qualifying Accounts
DescriptionBalance at
Beginning of Period
Additions Deductions Balance at
End of Period
 (In millions)
Fiscal year 2024
      
Allowance for doubtful accounts$$— (1)$— (1)$
Sales return allowance$26 $213 (2)$(130)(4)$109 
Deferred tax valuation allowance$1,484 $162 (3)$(94)(3)$1,552 
Fiscal year 2023
      
Allowance for doubtful accounts$$— (1)$— (1)$
Sales return allowance$13 $104 (2)$(91)(4)$26 
Deferred tax valuation allowance$907 $577 (3)$— $1,484 
Fiscal year 2022
      
Allowance for doubtful accounts$$— (1)$— (1)$
Sales return allowance$17 $19 (2)$(23)(4)$13 
Deferred tax valuation allowance$728 $179 (3)$— $907 
(1)Additions represent either expense or acquired balances and deductions represent write-offs.
(2)Additions represent estimated product returns charged as a reduction to revenue or an acquired balance.
(3)Additional valuation allowance on deferred tax assets not likely to be realized. Additions represent additional valuation allowance on capital loss carryforwards, and certain state and other deferred tax assets. Deductions represent the release of valuation allowance on certain state deferred tax assets. Refer to Note 14 of the Notes to the Consolidated Financial Statements in Part IV, Item 15 of this Annual Report on Form 10-K for additional information.
(4)Represents sales returns.
v3.24.0.1
Pay vs Performance Disclosure - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Pay vs Performance Disclosure      
Net income $ 29,760 $ 4,368 $ 9,752
v3.24.0.1
Insider Trading Arrangements
3 Months Ended 12 Months Ended
Jan. 28, 2024
shares
Jan. 28, 2024
shares
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On December 18, 2023, John O. Dabiri, a member of our Board of Directors, adopted a trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) for the sale through December 2, 2024 of an estimated 553 shares of our common stock, assuming our closing stock price as of January 26, 2024. The number of shares is based on an estimate because the plan specifies a formulaic dollar amount of shares to be sold.
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
John O. Dabiri [Member]    
Trading Arrangements, by Individual    
Name John O. Dabiri  
Title Director  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 18, 2023  
Arrangement Duration 350 days  
Aggregate Available 553 553
v3.24.0.1
Organization and Summary of Significant Accounting Policies (Policies)
12 Months Ended
Jan. 28, 2024
Accounting Policies [Abstract]  
Our Company
Our Company
Headquartered in Santa Clara, California, NVIDIA was incorporated in California in April 1993 and reincorporated in Delaware in April 1998.
All references to “NVIDIA,” “we,” “us,” “our” or the “Company” mean NVIDIA Corporation and its subsidiaries.
Fiscal Year
Fiscal Year
We operate on a 52- or 53-week year, ending on the last Sunday in January. Fiscal years 2024, 2023 and 2022 were all 52-week years.
Principles of Consolidation
Principles of Consolidation
Our consolidated financial statements include the accounts of NVIDIA Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from our estimates. On an on-going basis, we evaluate our estimates, including those related to revenue recognition, cash equivalents and marketable securities, accounts receivable, inventories and product purchase commitments, income taxes, goodwill, stock-based compensation, litigation, investigation and settlement costs, restructuring and other charges, property, plant, and equipment, and other contingencies. These estimates are based on historical facts and various other assumptions that we believe are reasonable.
In February 2023, we assessed the useful lives of our property, plant, and equipment. Based on advances in technology and usage rate, we increased the estimated useful life of most of our server, storage, and network equipment from three to four or five years, and our assembly and test equipment from five to seven years. The effect of this change for the fiscal year ended January 28, 2024 was a benefit of $33 million and $102 million for cost of revenue and operating expenses, respectively, which resulted in an increase in operating income of $135 million and net income of $114 million after tax, or $0.05 per both basic and diluted share.
Revenue Recognition
Revenue Recognition
We derive our revenue from product sales, including hardware and systems, license and development arrangements, software licensing, and cloud services. We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract (where revenue is allocated on a relative standalone selling price basis by maximizing the use of observable inputs to determine the standalone selling price for each performance obligation); and (5) recognition of revenue when, or as, we satisfy a performance obligation.
Product Sales Revenue
Revenue from product sales is recognized upon transfer of control of products to customers in an amount that reflects the consideration we expect to receive in exchange for those products. Certain products are sold with support or an extended warranty for the incorporated system, hardware, and/or software. Support and extended warranty revenue are recognized ratably over the service period, or as services are performed. Revenue is recognized net of allowances for returns, customer programs and any taxes collected from customers.
For products sold with a right of return, we record a reduction to revenue by establishing a sales return allowance for estimated product returns at the time revenue is recognized, based primarily on historical return rates. However, if product returns for a fiscal period are anticipated to exceed historical return rates, we may determine that additional sales return allowances are required to accurately reflect our estimated exposure for product returns.
Our customer programs involve rebates, which are designed to serve as sales incentives to resellers of our products in various target markets, and marketing development funds, or MDFs, which represent monies paid to our partners that are earmarked for market segment development and are designed to support our partners’ activities while also promoting NVIDIA products. We account for customer programs as a reduction to revenue and accrue for such programs for potential rebates and MDFs based on the amount we expect to be claimed by customers.
License and Development Arrangements
Our license and development arrangements with customers typically require significant customization of our IP components. As a result, we recognize the revenue from the license and the revenue from the development services as a single performance obligation over the period in which the development services are performed. We measure progress to completion based on actual cost incurred to date as a percentage of the estimated total cost required to complete each project. If a loss on an arrangement becomes probable during a period, we record a provision for such loss in that period.
Software Licensing
Our software licenses provide our customers with a right to use the software when it is made available to the customer. Customers may purchase either perpetual licenses or subscriptions to licenses, which differ mainly in the duration over which the customer benefits from the software. Software licenses are frequently sold along with the right to receive, on a when-and-if available basis, future unspecified software updates and upgrades. Revenue from software licenses is recognized up front when the software is made available to the customer. Software support revenue is recognized ratably over the service period, or as services are performed.
Cloud Services
Cloud services, which allow customers to use hosted software and hardware infrastructure without taking possession of the software or hardware, are provided on a subscription basis or a combination of subscription plus usage. Revenue related to subscription-based cloud services is recognized ratably over the contract period. Revenue related to cloud services based on usage is recognized as usage occurs. Cloud services are typically sold on a standalone basis, but certain offerings may be sold with hardware and/or software and related support.
Contracts with Multiple Performance Obligations
Our contracts may contain more than one of the products and services listed above, each of which is separately accounted for as a distinct performance obligation. We account for multiple agreements with a single customer as a single contract if the contractual terms and/or substance of those agreements indicate that they may be so closely related that they are, in effect, parts of a single contract.
We allocate the total transaction price to each distinct performance obligation in a multiple performance obligations arrangement on a relative standalone selling price basis. The standalone selling price reflects the price we would charge for a specific product or service if it were sold separately in similar circumstances and to similar customers. When determining standalone selling price, we maximize the use of observable inputs.
If a contract contains a single performance obligation, no allocation is required.
Product Warranties
Product Warranties
We offer a limited warranty to end-users ranging from one to three years for products to repair or replace products for manufacturing defects or hardware component failures. Cost of revenue includes the estimated cost of product warranties that are calculated at the point of revenue recognition. Under limited circumstances, we may offer an extended limited warranty to customers for certain products. We also accrue for known warranty and indemnification issues if a loss is probable and can be reasonably estimated.
Stock-based Compensation
Stock-based Compensation
We use the closing trading price of our common stock on the date of grant, minus a dividend yield discount, as the fair value of awards of restricted stock units, or RSUs, and performance stock units that are based on our corporate financial performance targets, or PSUs. We use a Monte Carlo simulation on the date of grant to estimate the fair value of performance stock units that are based on market conditions, or market-based PSUs. The compensation expense for RSUs and market-based PSUs is recognized using a straight-line attribution method over the requisite employee service period while compensation expense for PSUs is recognized using an accelerated amortization model. We estimate the fair value of shares to be issued under our employee stock purchase plan, or ESPP, using the Black-Scholes model at the commencement of an offering period in March and September of each year. Stock-based compensation for our ESPP is expensed using an accelerated amortization model. Additionally, for RSU, PSU, and market-based PSU awards, we estimate forfeitures semi-annually and revise the estimates of forfeiture in subsequent periods if actual forfeitures differ from those estimates. Forfeitures are estimated based on historical experience.
Litigation, Investigation and Settlement Costs
Litigation, Investigation and Settlement Costs
We currently, are, and will likely continue to be subject to claims, litigation, and other actions, including potential regulatory proceedings, involving patent and other intellectual property matters, taxes, labor and employment, competition and antitrust, commercial disputes, goods and services offered by us and by third parties, and other matters. There are many uncertainties associated with any litigation or investigation, and we cannot be certain that these actions
or other third-party claims against us will be resolved without litigation, fines and/or substantial settlement payments or judgments. If information becomes available that causes us to determine that a loss in any of our pending litigation, investigations or settlements is probable, and we can reasonably estimate the loss associated with such events, we will record the loss in accordance with U.S. GAAP. However, the actual liability in any such litigation or investigation may be materially different from our estimates, which could require us to record additional costs.
Foreign Currency Remeasurement
Foreign Currency Remeasurement
We use the U.S. dollar as our functional currency for our subsidiaries. Foreign currency monetary assets and liabilities are remeasured into United States dollars at end-of-period exchange rates. Non-monetary assets and liabilities such as property and equipment and equity are remeasured at historical exchange rates. Revenue and expenses are remeasured at exchange rates in effect during each period, except for those expenses related to non-monetary balance sheet amounts, which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in earnings in our Consolidated Statements of Income and to date have not been significant.
Income Taxes
Income Taxes
We recognize federal, state and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. We recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects attributable to temporary differences and carryforwards; and we record a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment, are not expected to be realized.
Our calculation of deferred tax assets and liabilities is based on certain estimates and judgments and involves dealing with uncertainties in the application of complex tax laws. Our estimates of deferred tax assets and liabilities may change based, in part, on added certainty or finality to an anticipated outcome, changes in accounting standards or tax laws in the U.S., or foreign jurisdictions where we operate, or changes in other facts or circumstances. In addition, we recognize liabilities for potential U.S. and foreign income tax contingencies based on our estimate of whether, and the extent to which, additional taxes may be due. If we determine that payment of these amounts is unnecessary or if the recorded tax liability is less than our current assessment, we may be required to recognize an income tax benefit or additional income tax expense in our financial statements accordingly.
As of January 28, 2024, we had a valuation allowance of $1.6 billion related to capital loss carryforwards, and certain state and other deferred tax assets that management determined are not likely to be realized due, in part, to jurisdictional projections of future taxable income, including capital gains. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax assets as income tax benefits during the period.
We recognize the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. Our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense.
Net Income Per Share
Net Income Per Share
Basic net income per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common and potentially dilutive shares outstanding during the period, using the treasury stock method. Any anti-dilutive effect of equity awards outstanding is not included in the computation of diluted net income per share.
Cash and Cash Equivalents and Marketable Securities
Cash and Cash Equivalents and Marketable Securities
We consider all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents. Marketable securities consist of highly liquid debt investments with maturities of greater than three months when purchased. We currently classify our investments as current based on the nature of the investments and their availability for use in current operations.
We classify our cash equivalents and marketable securities related to debt securities at the date of acquisition as available-for-sale. These available-for-sale debt securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. The fair value of interest-bearing debt securities includes accrued interest. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in the other income (expense), net, section of our Consolidated Statements of Income.
Available-for-sale debt investments are subject to a periodic impairment review. If the estimated fair value of available-for-sale debt securities is less than its amortized cost basis, we determine if the difference, if any, is caused by expected credit losses and write-down the amortized cost basis of the securities if it is more likely than not we will be required or
we intend to sell the securities before recovery of its amortized cost basis. Allowances for credit losses and write-downs are recognized in the other income (expense), net section of our Consolidated Statements of Income.
Cash and Cash Equivalents and Marketable Securities
Cash and Cash Equivalents and Marketable Securities
We consider all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents. Marketable securities consist of highly liquid debt investments with maturities of greater than three months when purchased. We currently classify our investments as current based on the nature of the investments and their availability for use in current operations.
We classify our cash equivalents and marketable securities related to debt securities at the date of acquisition as available-for-sale. These available-for-sale debt securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. The fair value of interest-bearing debt securities includes accrued interest. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in the other income (expense), net, section of our Consolidated Statements of Income.
Available-for-sale debt investments are subject to a periodic impairment review. If the estimated fair value of available-for-sale debt securities is less than its amortized cost basis, we determine if the difference, if any, is caused by expected credit losses and write-down the amortized cost basis of the securities if it is more likely than not we will be required or
we intend to sell the securities before recovery of its amortized cost basis. Allowances for credit losses and write-downs are recognized in the other income (expense), net section of our Consolidated Statements of Income.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The carrying value of cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their relatively short maturities as of January 28, 2024 and January 29, 2023. Marketable securities are comprised of available-for-sale securities that are reported at fair value with the related unrealized gains or losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. Fair value of the marketable securities is determined based on quoted market prices. Derivative instruments are recognized as either assets or liabilities and are measured at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. For derivative instruments designated as fair value hedges, the gains or losses are recognized in earnings in the periods of change together with the offsetting losses or gains on the hedged items attributed to the risk being hedged. For derivative instruments designated as cash-flow hedges, the effective portion of the gains or losses on the derivatives is initially reported as a component of other comprehensive income or loss and is subsequently recognized in earnings when the hedged exposure is recognized in earnings. For derivative instruments not designated for hedge accounting, changes in fair value are recognized in earnings.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, marketable securities, and accounts receivable. Our investment policy requires the purchase of highly-rated fixed income securities, the diversification of investment type and credit exposures, and includes certain limits on our portfolio duration. We perform ongoing credit evaluations of our customers’ financial condition and maintain an allowance for potential credit losses. This allowance consists of an amount identified for specific customers and an amount based on overall estimated exposure. Our overall estimated exposure excludes amounts covered by credit insurance and letters of credit.
Inventories
Inventories
Inventory cost is computed on an adjusted standard basis, which approximates actual cost on an average or first-in, first-out basis. Inventory costs consist primarily of the cost of semiconductors, including wafer fabrication, assembly, testing and packaging, manufacturing support costs, including labor and overhead associated with such purchases, final test yield fallout, and shipping costs, as well as the cost of purchased memory products and other component parts. We charge cost of sales for inventory provisions to write-down our inventory to the lower of cost or net realizable value or for obsolete or excess inventory, and for excess product purchase commitments. Most of our inventory provisions relate to excess quantities of products, based on our inventory levels and future product purchase commitments compared to assumptions about future demand and market conditions. Once inventory has been written-off or written-down, it creates a new cost basis for the inventory that is not subsequently written-up. We record a liability for noncancelable purchase commitments with suppliers for quantities in excess of our future demand forecasts consistent with our valuation of obsolete or excess inventory.
Property and Equipment
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation. Depreciation of property and equipment is computed using the straight-line method based on the estimated useful lives of the assets of three to seven years. Once an asset is identified for retirement or disposition, the related cost and accumulated depreciation or amortization are removed, and a gain or loss is recorded. The estimated useful lives of our buildings are up to thirty years. Depreciation expense includes the amortization of assets recorded under finance leases. Leasehold improvements and assets recorded under finance leases are amortized over the shorter of the expected lease term or the estimated useful life of the asset.
Leases
Leases
We determine if an arrangement is or contains a lease at inception. Operating leases with lease terms of more than 12 months are included in operating lease assets, accrued and other current liabilities, and long-term operating lease liabilities on our consolidated balance sheet. Operating lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments over the lease term.
Operating lease assets and liabilities are recognized based on the present value of the remaining lease payments discounted using our incremental borrowing rate. Operating lease assets also include initial direct costs incurred and prepaid lease payments, minus any lease incentives. Our lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense is recognized on a straight-line basis over the lease term.
We combine the lease and non-lease components in determining the operating lease assets and liabilities.
Goodwill
Goodwill
Goodwill is subject to our annual impairment test during the fourth quarter of our fiscal year, or earlier if indicators of potential impairment exist. In completing our impairment test, we perform either a qualitative or a quantitative analysis on a reporting unit basis. 
Qualitative factors include industry and market considerations, overall financial performance, and other relevant events and factors affecting the reporting units.
The quantitative impairment test considers both the income approach and the market approach to estimate a reporting unit’s fair value. The income and market valuation approaches consider factors that include, but are not limited to, prospective financial information, growth rates, residual values, discount rates and comparable multiples from publicly traded companies in our industry and require us to make certain assumptions and estimates regarding industry economic factors and the future profitability of our business.
Intangible Assets and Other Long-Lived Assets
Intangible Assets and Other Long-Lived Assets
Intangible assets primarily represent acquired intangible assets including developed technology and customer relationships, as well as rights acquired under technology licenses, patents, and acquired IP. We currently amortize our intangible assets with finite lives over periods ranging from one to twenty years using a method that reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up or, if that pattern cannot be reliably determined, using a straight-line amortization method.
Long-lived assets, such as property and equipment and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. The recoverability of assets or asset groups to be held and used is measured by a comparison of the carrying amount of an asset or asset group to estimated undiscounted future cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset or asset group exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset or asset group exceeds the estimated fair value of the asset or asset group. Fair value is determined based on the estimated discounted future cash flows expected to be generated by the asset or asset group. Assets and liabilities to be disposed of would be separately presented in the Consolidated Balance Sheet and the assets would be reported at the lower of the carrying amount or fair value less costs to sell, and would no longer be depreciated.
Business Combination
Business Combination
We allocate the fair value of the purchase price of an acquisition to the tangible assets acquired, liabilities assumed, and intangible assets acquired, based on their estimated fair values. The excess of the fair value of the purchase price over the fair values of these net tangible and intangible assets acquired is recorded as goodwill. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but our estimates and assumptions are inherently uncertain and subject to refinement. The estimates and assumptions used in valuing intangible assets include, but are not limited to, the amount and timing of projected future cash flows, discount rate used to determine the present value of these cash flows and asset lives. These estimates are inherently uncertain and, therefore, actual results may differ from the estimates made. As a result, during the measurement period of up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the measurement period's conclusion or final determination of the fair value of the purchase price of an acquisition, whichever comes first, any subsequent adjustments are recorded to our Consolidated Statements of Income.
Acquisition-related expenses are recognized separately from the business combination and expensed as incurred.
Investment in Non-Affiliated Entities
Investments in Non-Affiliated Entities
Our investment in non-affiliates consists of marketable equity securities, which are publicly traded, and non-marketable equity securities, which are investments in privately held companies. Marketable equity securities have readily determinable fair values with changes in fair value recorded in other income (expense), net. Non-marketable equity securities include investments that do not have a readily determinable fair value. The investments that do not have readily determinable fair value are measured at cost minus impairment, if any, and are adjusted for changes resulting from observable price changes in orderly transactions for an identical or similar investment in the same issuer, or the measurement alternative. Fair value is based upon observable inputs in an inactive market and the valuation requires our judgment due to the absence of market prices and inherent lack of liquidity. All gains and losses on these investments, realized and unrealized, are recognized in other income (expense), net on our Consolidated Statements of Income.
We assess whether an impairment loss has occurred on our investments in non-marketable equity securities, accounted for under the measurement alternative based on quantitative and qualitative factors. If any impairment is identified for non-marketable equity securities, we write down the investment to its fair value and record the corresponding charge through other income (expense), net on our Consolidated Statements of Income.
Recently Issued Accounting Pronouncements
Recently Issued Accounting Pronouncements
Recent Accounting Pronouncements Not Yet Adopted
In November 2023, the Financial Accounting Standards Board, or FASB, issued a new accounting standard to provide for additional disclosures about significant expenses in operating segments. The standard is effective for our annual reporting for fiscal year 2025 and for interim period reporting starting in fiscal year 2026 retrospectively. We are currently evaluating the impact of this standard on our Consolidated Financial Statements.
In December 2023, the FASB issued a new accounting standard which provides for new and changes to income tax disclosures including disaggregation of the rate reconciliation and income taxes paid disclosures. The amendments in the standard are effective for annual periods beginning after December 15, 2024. Early adoption is permitted and should be applied prospectively, with retrospective application permitted. We expect to adopt this standard in our annual period beginning fiscal year 2026. We are currently evaluating the impact of this standard on our Consolidated Financial Statements.
v3.24.0.1
Leases (Tables)
12 Months Ended
Jan. 28, 2024
Leases [Abstract]  
Schedule of Future Minimum Lease Payments
Future minimum lease payments under our non-cancelable operating leases as of January 28, 2024, are as follows:
Operating Lease Obligations
 (In millions)
Fiscal Year: 
2025$290 
2026270 
2027253 
2028236 
2029202 
2030 and thereafter288 
Total1,539 
Less imputed interest192 
Present value of net future minimum lease payments1,347 
Less short-term operating lease liabilities228 
Long-term operating lease liabilities$1,119 
Schedule of Other Information Related to Leases
Other information related to leases was as follows:
Year Ended
Jan 28, 2024Jan 29, 2023Jan 30, 2022
 (In millions)
Supplemental cash flows information 
Operating cash flows used for operating leases$286 $184 $154 
Operating lease assets obtained in exchange for lease obligations$531 $358 $266 
v3.24.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Jan. 28, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense, Net of Amounts Capitalized as Inventory
Our Consolidated Statements of Income include stock-based compensation expense, net of amounts allocated to inventory, as follows:
 Year Ended
Jan 28, 2024Jan 29, 2023Jan 30, 2022
 (In millions)
Cost of revenue$141 $138 $141 
Research and development2,532 1,892 1,298 
Sales, general and administrative876 680 565 
Total$3,549 $2,710 $2,004 
Schedule of Equity Awards
The following is a summary of equity awards granted under our equity incentive plans:
Year Ended
Jan 28, 2024Jan 29, 2023Jan 30, 2022
(In millions, except per share data)
RSUs, PSUs and Market-based PSUs
Awards granted14 25 18 
Estimated total grant-date fair value$5,316 $4,505 $3,492 
Weighted average grant-date fair value per share$374.08 $183.72 $190.69 
ESPP
Shares purchased
Weighted average price per share$158.07 $122.54 $56.36 
Weighted average grant-date fair value per share$69.90 $51.87 $23.24 
Schedule of ESPP Valuation Assumptions
The fair value of shares issued under our ESPP have been estimated with the following assumptions:
 Year Ended
 Jan 28, 2024Jan 29, 2023Jan 30, 2022
(Using the Black-Scholes model)
ESPP
Weighted average expected life (in years)
0.1-2.0
0.1-2.0
0.1-2.0
Risk-free interest rate
3.9%-5.5%
—%-4.6%
—%-0.5%
Volatility
31%-67%
43%-72%
20%-58%
Dividend yield
0.1%
0.1%
0.1%
Schedule of Equity Award Transactions
The following is a summary of our equity award transactions under our equity incentive plans: 
RSUs, PSUs and Market-based PSUs Outstanding
 Number of SharesWeighted Average Grant-Date Fair Value
(In millions, except per share data)
Balances, Jan 29, 202345 $158.45 
Granted14 $374.08 
Vested restricted stock(21)$148.56 
Canceled and forfeited(1)$206.35 
Balances, Jan 28, 202437 $245.94 
Vested and expected to vest after Jan 28, 202437 $245.49 
v3.24.0.1
Net Income Per Share (Tables)
12 Months Ended
Jan. 28, 2024
Earnings Per Share [Abstract]  
Schedule of Reconciliation of Numerators and Denominators of Basic and Diluted net Income Per Share Computations
The following is a reconciliation of the denominator of the basic and diluted net income per share computations for the periods presented:
 Year Ended
 Jan 28, 2024Jan 29, 2023Jan 30, 2022
 (In millions, except per share data)
Numerator:   
Net income$29,760 $4,368 $9,752 
Denominator:   
Basic weighted average shares2,469 2,487 2,496 
Dilutive impact of outstanding equity awards25 20 39 
Diluted weighted average shares2,494 2,507 2,535 
Net income per share:   
Basic (1)$12.05 $1.76 $3.91 
Diluted (2)$11.93 $1.74 $3.85 
Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive
15 40 21 
(1)    Calculated as net income divided by basic weighted average shares.
(2)    Calculated as net income divided by diluted weighted average shares.
v3.24.0.1
Amortizable Intangible Assets (Tables)
12 Months Ended
Jan. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of the Components of Our Amortizable Intangible Assets
The components of our amortizable intangible assets are as follows:
 Jan 28, 2024Jan 29, 2023
 
Gross
Carrying
Amount
Accumulated
Amortization
Net 
Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net 
Carrying
Amount
 (In millions)
Acquisition-related intangible assets (1)$2,642 $(1,720)$922 $3,093 $(1,614)$1,479 
Patents and licensed technology449 (259)190 446 (249)197 
Total intangible assets$3,091 $(1,979)$1,112 $3,539 $(1,863)$1,676 
(1)    During the first quarter of fiscal year 2023, we commenced amortization of a $630 million in-process research and development intangible asset related to our acquisition of Mellanox.
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
The following table outlines the estimated future amortization expense related to the net carrying amount of intangible assets as of January 28, 2024:
Future Amortization Expense
 (In millions)
Fiscal Year: 
2025$555 
2026261 
2027150 
202837 
2029
2030 and thereafter100 
Total$1,112 
v3.24.0.1
Cash Equivalents and Marketable Securities (Tables)
12 Months Ended
Jan. 28, 2024
Investments, Debt and Equity Securities [Abstract]  
Schedule of Cash Equivalents and Marketable Securities
The following is a summary of cash equivalents and marketable securities:

 Jan 28, 2024
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value
Reported as
 Cash EquivalentsMarketable Securities
 (In millions)
Corporate debt securities$10,126 $31 $(5)$10,152 $2,231 $7,921 
Debt securities issued by the U.S. Treasury9,517 17 (10)9,524 1,315 8,209 
Debt securities issued by U.S. government agencies2,326 (1)2,333 89 2,244 
Money market funds3,031 — — 3,031 3,031 — 
Certificates of deposit510 — — 510 294 216 
Foreign government bonds174 — — 174 60 114 
Total$25,684 $56 $(16)$25,724 $7,020 $18,704 

 Jan 29, 2023
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value
Reported as
 Cash EquivalentsMarketable Securities
 (In millions)
Corporate debt securities$4,809 $— $(12)$4,797 $1,087 $3,710 
Debt securities issued by the U.S. Treasury4,185 (44)4,142 — 4,142 
Debt securities issued by U.S. government agencies1,836 — (2)1,834 50 1,784 
Money market funds1,777 — — 1,777 1,777 — 
Certificates of deposit365 — — 365 134 231 
Foreign government bonds140 — — 140 100 40 
Total$13,112 $$(58)$13,055 $3,148 $9,907 
The amortized cost and estimated fair value of cash equivalents and marketable securities are shown below by contractual maturity.
 Jan 28, 2024Jan 29, 2023
 Amortized
Cost
Estimated
Fair Value
Amortized
Cost
Estimated
Fair Value
 (In millions)
Less than one year$16,336 $16,329 $9,738 $9,708 
Due in 1 - 5 years9,348 9,395 3,374 3,347 
Total$25,684 $25,724 $13,112 $13,055 
Schedule of Marketable Securities in a Continuous Unrealized Loss Position
The following tables provide the breakdown of unrealized losses, aggregated by investment category and length of time that individual securities have been in a continuous loss position:
Jan 28, 2024
 Less than 12 Months12 Months or GreaterTotal
 Estimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized Loss
 (In millions)
Debt securities issued by the U.S. Treasury$3,343 $(5)$1,078 $(5)$4,421 $(10)
Corporate debt securities1,306 (3)618 (2)1,924 (5)
Debt securities issued by U.S. government agencies670 (1)— — 670 (1)
Total$5,319 $(9)$1,696 $(7)$7,015 $(16)
Jan 29, 2023
 Less than 12 Months12 Months or GreaterTotal
 Estimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized Loss
 (In millions)
Debt securities issued by the U.S. Treasury$2,444 $(21)$1,172 $(23)$3,616 $(44)
Corporate debt securities1,188 (7)696 (5)1,884 (12)
Debt securities issued by U.S. government agencies1,307 (2)— — 1,307 (2)
Total$4,939 $(30)$1,868 $(28)$6,807 $(58)
v3.24.0.1
Fair Value of Financial Assets and Liabilities and Investments in Non-Affiliated Entities (Tables)
12 Months Ended
Jan. 28, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Financial Assets and Liabilities
Fair Value at
Pricing CategoryJan 28, 2024Jan 29, 2023
(In millions)
Assets
Cash equivalents and marketable securities:
Money market fundsLevel 1$3,031 $1,777 
Corporate debt securitiesLevel 2$10,152 $4,797 
Debt securities issued by the U.S. TreasuryLevel 2$9,524 $4,142 
Debt securities issued by U.S. government agenciesLevel 2$2,333 $1,834 
Certificates of depositLevel 2$510 $365 
Foreign government bondsLevel 2$174 $140 
Other assets (Investment in non-affiliated entities):
Publicly-held equity securitiesLevel 1$225 $11 
Liabilities (1)
0.309% Notes Due 2023
Level 2$— $1,230 
0.584% Notes Due 2024
Level 2$1,228 $1,185 
3.20% Notes Due 2026
Level 2$970 $966 
1.55% Notes Due 2028
Level 2$1,115 $1,099 
2.85% Notes Due 2030
Level 2$1,367 $1,364 
2.00% Notes Due 2031
Level 2$1,057 $1,044 
3.50% Notes Due 2040
Level 2$851 $870 
3.50% Notes Due 2050
Level 2$1,604 $1,637 
3.70% Notes Due 2060
Level 2$403 $410 
(1)    These liabilities are carried on our Consolidated Balance Sheets at their original issuance value, net of unamortized debt discount and issuance costs.
Equity Securities without Readily Determinable Fair Value
Adjustments to the carrying value of our non-marketable equity securities accounted for under the measurement alternative were as follows:
Year Ended
Jan 28, 2024
(In millions)
Carrying amount as of Jan 29, 2023$288 
Adjustments related to non-marketable equity securities:
Net additions859 
Unrealized gains194 
Impairments and unrealized losses(20)
Carrying amount as of Jan 28, 2024$1,321 
The following table summarizes the cumulative gross unrealized gains and cumulative gross unrealized losses and impairments related to non-marketable equity securities accounted for under the measurement alternative:
Jan 28, 2024
(In millions)
Cumulative gross unrealized gains$270 
Cumulative gross unrealized losses and impairments(45)
v3.24.0.1
Balance Sheet Components (Tables)
12 Months Ended
Jan. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Inventory
Certain balance sheet components are as follows:
 Jan 28, 2024Jan 29, 2023
(In millions)
Inventories (1):
Raw materials$1,719 $2,430 
Work in-process1,505 466 
Finished goods2,058 2,263 
Total inventories$5,282 $5,159 
(1) In fiscal years 2024 and 2023, we recorded an inventory provision of $774 million and $1.0 billion, respectively, in cost of revenue.
Schedule of Property and Equipment
 Jan 28, 2024Jan 29, 2023Estimated
Useful Life
(In millions)(In years)
Property and Equipment:
Land$218 $218 (A)
Buildings, leasehold improvements, and furniture1,816 1,598 (B)
Equipment, compute hardware, and software5,200 4,303 
3-7
Construction in process189 382 (C)
Total property and equipment, gross7,423 6,501  
Accumulated depreciation and amortization(3,509)(2,694) 
Total property and equipment, net$3,914 $3,807  
(A)Land is a non-depreciable asset.
(B)The estimated useful lives of our buildings are up to thirty years. Leasehold improvements and finance leases are amortized based on the lesser of either the asset’s estimated useful life or the expected remaining lease term.
(C)Construction in process represents assets that are not available for their intended use as of the balance sheet date.
Schedule of Other Assets
 Jan 28, 2024Jan 29, 2023
Other assets:(In millions)
Prepaid supply and capacity agreements (1)$2,458 $2,989 
Investments in non-affiliated entities1,546 299 
Prepaid royalties364 387 
Other132 145 
Total other assets$4,500 $3,820 
(1)As of January 28, 2024 and January 29, 2023, there was an additional $2.5 billion and $458 million of short-term prepaid supply and capacity agreements included in Prepaid expenses and other current assets, respectively.
Schedule of Accrued and Other Current Liabilities
 Jan 28, 2024Jan 29, 2023
(In millions)
Accrued and Other Current Liabilities:
Customer program accruals$2,081 $1,196 
Excess inventory purchase obligations (1)1,655 954 
Deferred revenue (2)764 354 
Accrued payroll and related expenses675 530 
Product warranty and return provisions415 108 
Taxes payable296 467 
Operating leases228 176 
Unsettled share repurchases187 117 
Licenses and royalties182 149 
Other199 69 
Total accrued and other current liabilities$6,682 $4,120 
(1)In fiscal years 2024 and 2023, we recorded an expense of approximately $1.4 billion and $1.1 billion, respectively, in cost of revenue for inventory purchase obligations in excess of our current demand projections, supplier charges and for penalties related to cancellations and underutilization.
(2)Deferred revenue primarily includes customer advances and deferrals related to support for hardware and software, license and development arrangements, and cloud services. $233 million and $35 million of the balance in fiscal 2024 and 2023 respectively, related to customer advances.
Schedule of Other Long-term Liabilities
 Jan 28, 2024Jan 29, 2023
(In millions)
Other Long-Term Liabilities:
Income tax payable (1)$1,361 $1,204 
Deferred income tax462 247 
Deferred revenue (2)573 218 
Licenses payable80 181 
Other65 63 
Total other long-term liabilities$2,541 $1,913 
(1)Income tax payable is comprised of the long-term portion of the one-time transition tax payable, unrecognized tax benefits, and related interest and penalties.
(2)Deferred revenue primarily includes deferrals related to support for hardware and software.
Schedule of Changes in Deferred Revenue
The following table shows the changes in deferred revenue during fiscal years 2024 and 2023.
 Jan 28, 2024Jan 29, 2023
(In millions)
Balance at beginning of period$572 $502 
Deferred revenue additions during the period2,038 830 
Revenue recognized during the period(1,273)(760)
Balance at end of period$1,337 $572 
v3.24.0.1
Derivative Financial Instruments (Tables)
12 Months Ended
Jan. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Notional Value of Our Foreign Currency Forward Contracts Outstanding
The table below presents the notional value of our foreign currency forward contracts outstanding:

Jan 28, 2024Jan 29, 2023
 (In millions)
Designated as cash flow hedges$1,168 $1,128 
Non-designated hedges$597 $366 
v3.24.0.1
Debt (Tables)
12 Months Ended
Jan. 28, 2024
Debt Disclosure [Abstract]  
Schedule of Long-term Debt
The carrying value of our outstanding notes, the calendar year of maturity, and the associated interest rates were as follows:
 Expected
Remaining Term (years)
Effective
Interest Rate
Jan 28, 2024Jan 29, 2023
   (In millions)
0.309% Notes Due 2023 (1)
0.41%$— $1,250 
0.584% Notes Due 2024
0.40.66%1,250 1,250 
3.20% Notes Due 2026
2.63.31%1,000 1,000 
1.55% Notes Due 2028
4.41.64%1,250 1,250 
2.85% Notes Due 2030
6.22.93%1,500 1,500 
2.00% Notes Due 2031
7.42.09%1,250 1,250 
3.50% Notes Due 2040
16.23.54%1,000 1,000 
3.50% Notes Due 2050
26.23.54%2,000 2,000 
3.70% Notes Due 2060
36.23.73%500 500 
Unamortized debt discount and issuance costs  (41)(47)
Net carrying amount  9,709 10,953 
Less short-term portion(1,250)(1,250)
Total long-term portion$8,459 $9,703 
(1) In fiscal year 2024, we repaid the 0.309% Notes Due 2023.
v3.24.0.1
Commitments and Contingencies (Tables)
12 Months Ended
Jan. 28, 2024
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Purchase Obligation, Fiscal Year Maturity
Total future purchase commitments as of January 28, 2024 are as follows:
Commitments
 (In millions)
Fiscal Year: 
2025$17,316 
20261,143 
20271,060 
2028770 
2029 and thereafter418 
Total$20,707 
Schedule of Product Warranty Activity The estimated product returns and estimated product warranty activity consisted of the following:
Year Ended
Jan 28, 2024Jan 29, 2023Jan 30, 2022
(In millions)
Balance at beginning of period$82 $46 $22 
Additions278 14540
Utilization(54)(109)(16)
Balance at end of period$306 $82 $46 
v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Jan. 28, 2024
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Expense (benefit)
The income tax expense (benefit) applicable to income before income taxes consists of the following:
 Year Ended
 Jan 28, 2024Jan 29, 2023Jan 30, 2022
 (In millions)
Current income taxes:   
Federal$5,710 $1,703 $482 
State335 46 42 
Foreign502 228 71 
Total current6,547 1,977 595 
Deferred income taxes:   
Federal(2,499)(2,165)(420)
State(206)— — 
Foreign216 14 
Total deferred(2,489)(2,164)(406)
Income tax expense (benefit)$4,058 $(187)$189 
Schedule of Income Before Income Tax
Income before income tax consists of the following:
 Year Ended
 Jan 28, 2024Jan 29, 2023Jan 30, 2022
 (In millions)
U.S.$29,495 $3,477 $8,446 
Foreign4,323 704 1,495 
Income before income tax$33,818 $4,181 $9,941 
Schedule of Effective Income Tax Rate Reconciliation
The income tax expense (benefit) differs from the amount computed by applying the U.S. federal statutory rate of 21% to income before income taxes as follows:
 Year Ended
 Jan 28, 2024Jan 29, 2023Jan 30, 2022
 (In millions, except percentages)
Tax expense computed at federal statutory rate$7,102 21.0 %$878 21.0 %$2,088 21.0 %
Expense (benefit) resulting from:
State income taxes, net of federal tax effect120 0.4 %50 1.2 %42 0.4 %
Foreign-derived intangible income(1,408)(4.2)%(739)(17.7)%(520)(5.2)%
Stock-based compensation(741)(2.2)%(309)(7.4)%(337)(3.4)%
Foreign tax rate differential(467)(1.4)%(83)(2.0)%(497)(5.0)%
U.S. federal research and development tax credit(431)(1.3)%(278)(6.6)%(289)(2.9)%
Acquisition termination cost— — %261 6.2 %— — %
IP domestication— — %— — %(244)(2.5)%
Other(117)(0.3)%33 0.8 %(54)(0.5)%
Income tax expense (benefit)$4,058 12.0 %$(187)(4.5)%$189 1.9 %
Schedule of Deferred Tax Assets and Liabilities
The tax effect of temporary differences that gives rise to significant portions of the deferred tax assets and liabilities are presented below:
 Jan 28, 2024Jan 29, 2023
 (In millions)
Deferred tax assets: 
Capitalized research and development expenditure$3,376 $1,859 
GILTI deferred tax assets1,576 800 
Accruals and reserves, not currently deductible for tax purposes1,121 686 
Research and other tax credit carryforwards936 951 
Net operating loss and capital loss carryforwards439 409 
Operating lease liabilities263 193 
Stock-based compensation106 99 
Property, equipment and intangible assets66 
Other deferred tax assets179 91 
Gross deferred tax assets8,000 5,154 
Less valuation allowance(1,552)(1,484)
Total deferred tax assets6,448 3,670 
Deferred tax liabilities:  
Unremitted earnings of foreign subsidiaries(502)(228)
Operating lease assets(255)(179)
Acquired intangibles(74)(115)
Gross deferred tax liabilities(831)(522)
Net deferred tax asset (1)$5,617 $3,148 
(1) Net deferred tax asset includes long-term deferred tax assets of $6.1 billion and $3.4 billion and long-term deferred tax liabilities of $462 million and $247 million for fiscal years 2024 and 2023, respectively. Long-term deferred tax liabilities are included in other long-term liabilities on our Consolidated Balance Sheets.
Schedule of Gross Unrecognized Tax Benefits
A reconciliation of gross unrecognized tax benefits is as follows:
 Jan 28, 2024Jan 29, 2023Jan 30, 2022
 (In millions)
Balance at beginning of period$1,238 $1,013 $776 
Increases in tax positions for current year616 268 246 
Increases in tax positions for prior years87 14 
Decreases in tax positions for prior years(148)(15)(4)
Settlements(104)(9)(8)
Lapse in statute of limitations(19)(20)(11)
Balance at end of period$1,670 $1,238 $1,013 
v3.24.0.1
Segment Information (Tables)
12 Months Ended
Jan. 28, 2024
Segment Reporting [Abstract]  
Schedule of Reportable Segments
 Compute & NetworkingGraphicsAll OtherConsolidated
(In millions)
Year Ended Jan 28, 2024:
   
Revenue$47,405 $13,517 $— $60,922 
Operating income (loss)$32,016 $5,846 $(4,890)$32,972 
Year Ended Jan 29, 2023:
   
Revenue$15,068 $11,906 $— $26,974 
Operating income (loss)$5,083 $4,552 $(5,411)$4,224 
Year Ended Jan 30, 2022:
   
Revenue$11,046 $15,868 $— $26,914 
Operating income (loss)$4,598 $8,492 $(3,049)$10,041 
Year Ended
Jan 28, 2024Jan 29, 2023Jan 30, 2022
(In millions)
Reconciling items included in "All Other" category:
Stock-based compensation expense$(3,549)$(2,710)$(2,004)
Unallocated cost of revenue and operating expenses(728)(595)(399)
Acquisition-related and other costs(583)(674)(636)
IP-related and legal settlement costs(40)(23)(10)
Restructuring costs and other— (54)— 
Acquisition termination cost— (1,353)— 
Other10 (2)— 
Total$(4,890)$(5,411)$(3,049)
Schedule of Revenue by Geographic Regions
 Year Ended
 Jan 28, 2024Jan 29, 2023Jan 30, 2022
Revenue:(In millions)
United States$26,966 $8,292 $4,349 
Taiwan13,405 6,986 8,544 
China (including Hong Kong)10,306 5,785 7,111 
Other countries10,245 5,911 6,910 
Total revenue$60,922 $26,974 $26,914 
Schedule of Revenue by Specialized Markets
The following table summarizes information pertaining to our revenue by each of the specialized markets we serve:
 Year Ended
 Jan 28, 2024Jan 29, 2023Jan 30, 2022
Revenue:(In millions)
Data Center$47,525 $15,005 $10,613 
Gaming10,447 9,067 12,462 
Professional Visualization1,553 1,544 2,111 
Automotive1,091 903 566 
OEM and Other306 455 1,162 
Total revenue$60,922 $26,974 $26,914 
Schedule of Long-Lived Assets by Geographic Region
The following table presents summarized information for long-lived assets by country. Long-lived assets consist of property and equipment and exclude other assets, operating lease assets, goodwill, and intangible assets.
 Jan 28, 2024Jan 29, 2023
Long-lived assets:(In millions)
United States$2,595 $2,587 
Taiwan773 702 
Israel325 283 
Other countries221 235 
Total long-lived assets$3,914 $3,807 
v3.24.0.1
Organization and Summary of Significant Accounting Policies (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Jan. 28, 2024
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Feb. 28, 2023
Jan. 31, 2023
Property, Plant and Equipment [Line Items]            
Cost of revenue benefit   $ (16,621) $ (11,618) $ (9,439)    
Operating expense benefit   (11,329) (11,132) (7,434)    
Net income   $ 29,760 $ 4,368 $ 9,752    
Basic (in USD per share)   $ 12.05 $ 1.76 $ 3.91    
Diluted (in USD per share)   $ 11.93 $ 1.74 $ 3.85    
Operating income (loss)   $ 32,972 $ 4,224 $ 10,041    
Valuation allowance $ 1,552 $ 1,552 $ 1,484      
Service Life            
Property, Plant and Equipment [Line Items]            
Cost of revenue benefit 33          
Operating expense benefit 102          
Net income $ 114          
Basic (in USD per share) $ 0.05          
Diluted (in USD per share) $ 0.05          
Operating income (loss) $ 135          
Server, Storage and Net work Equipment            
Property, Plant and Equipment [Line Items]            
Property, plant & equipment, useful life           3 years
Buildings            
Property, Plant and Equipment [Line Items]            
Property, plant & equipment, useful life 30 years 30 years        
Minimum            
Property, Plant and Equipment [Line Items]            
Property, plant & equipment, useful life 3 years 3 years        
Warranty liability, term   1 year        
Intangible assets, useful life 1 year 1 year        
Minimum | Server, Storage and Net work Equipment            
Property, Plant and Equipment [Line Items]            
Property, plant & equipment, useful life         4 years  
Minimum | Assembling and Testing Equipment            
Property, Plant and Equipment [Line Items]            
Property, plant & equipment, useful life           5 years
Maximum            
Property, Plant and Equipment [Line Items]            
Property, plant & equipment, useful life 7 years 7 years        
Warranty liability, term   3 years        
Intangible assets, useful life 20 years 20 years        
Maximum | Server, Storage and Net work Equipment            
Property, Plant and Equipment [Line Items]            
Property, plant & equipment, useful life         5 years  
Maximum | Assembling and Testing Equipment            
Property, Plant and Equipment [Line Items]            
Property, plant & equipment, useful life         7 years  
v3.24.0.1
Business Combination (Details)
$ in Billions
12 Months Ended
Jan. 29, 2023
USD ($)
Arm Limited  
Business Acquisition [Line Items]  
Transaction costs $ 1.4
v3.24.0.1
Leases - Schedule of Future Minimum Lease Payments (Details) - USD ($)
$ in Millions
Jan. 28, 2024
Jan. 29, 2023
Leases [Abstract]    
2025 $ 290  
2026 270  
2027 253  
2028 236  
2029 202  
2030 and thereafter 288  
Total 1,539  
Less imputed interest 192  
Present value of net future minimum lease payments $ 1,347  
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Accrued and other current liabilities Accrued and other current liabilities
Less short-term operating lease liabilities $ 228 $ 176
Long-term operating lease liabilities $ 1,119 $ 902
v3.24.0.1
Leases - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Lessee, Lease, Description [Line Items]      
Lease not yet commenced, undiscounted amount $ 1,100    
Operating lease expense $ 269 $ 193 $ 168
Weighted average remaining lease term - operating leases 6 years 1 month 6 days 6 years 9 months 18 days  
Weighted average discount rate - operating leases 3.76% 3.21%  
Minimum      
Lessee, Lease, Description [Line Items]      
Lease not yet commenced, term of contract 1 year    
Maximum      
Lessee, Lease, Description [Line Items]      
Lease not yet commenced, term of contract 10 years    
v3.24.0.1
Leases - Schedule of other lease information (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Leases [Abstract]      
Operating cash flows used for operating leases $ 286 $ 184 $ 154
Operating lease assets obtained in exchange for lease obligations $ 531 $ 358 $ 266
v3.24.0.1
Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense $ 3,549 $ 2,710 $ 2,004
Cost of revenue      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense 141 138 141
Research and development      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense 2,532 1,892 1,298
Sales, general and administrative      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense $ 876 $ 680 $ 565
v3.24.0.1
Stock-Based Compensation - Summary of Equity Awards (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 14    
Weighted average grant date fair value (in dollars per share) $ 374.08    
Summary of unearned SBC expense      
Unearned stock-based compensation expense $ 8,600    
RSUs, PSUs and Market-based PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 14 25 18
Estimated total grant-date fair value $ 5,316 $ 4,505 $ 3,492
Weighted average grant date fair value (in dollars per share) $ 374.08 $ 183.72 $ 190.69
Summary of unearned SBC expense      
Estimated weighted average amortization period 2 years 6 months    
Employee Stock Purchase Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 3 3 5
Weighted average price (in dollars per share) $ 158.07 $ 122.54 $ 56.36
Weighted average grant date fair value (in dollars per share) $ 69.90 $ 51.87 $ 23.24
Summary of unearned SBC expense      
Estimated weighted average amortization period 9 months 18 days    
Fair Value Assumptions      
Risk free interest rate, minimum 3.90% 0.00% 0.00%
Risk free interest rate, maximum 5.50% 4.60% 0.50%
Volatility rate, minimum 31.00% 43.00% 20.00%
Volatility rate, maximum 67.00% 72.00% 58.00%
Dividend yield 10.00% 0.10%  
Employee Stock Purchase Plan | Minimum      
Fair Value Assumptions      
Weighted average expected life (in years) 1 month 6 days 1 month 6 days 1 month 6 days
Dividend yield     0.10%
Employee Stock Purchase Plan | Maximum      
Fair Value Assumptions      
Weighted average expected life (in years) 2 years 2 years 2 years
v3.24.0.1
Stock-Based Compensation - Narrative (Details)
shares in Millions, $ in Billions
12 Months Ended
Jan. 28, 2024
USD ($)
period
shares
Jan. 29, 2023
USD ($)
shares
Jan. 30, 2022
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares may be issued under the Restated 2007 Plan (in shares) 37    
Number of shares available for grant (in shares) 147 160  
Employee stock purchase plan, offering period duration 24 months    
Employee stock purchase plan, number of purchase periods in offering period | period 4    
Employee stock purchase plan, purchase period duration 6 months    
RSUs, PSUs and Market-based PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares available for grant (in shares) 147    
Total fair value of units as of respective vesting dates | $ $ 8.2 $ 4.3 $ 5.6
Restricted Stock Units (RSUs) | Tranche One      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 4 years    
Vesting rights (as percent) 25.00%    
Quarterly vesting schedule - RSUs and PSUs (as percent) 6.25%    
Restricted Stock Units (RSUs) | Tranche Two      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 3 years    
Vesting rights (as percent) 40.00%    
Quarterly vesting schedule - RSUs and PSUs (as percent) 7.50%    
Restricted Stock Units (RSUs) | Tranche Three      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 4 years    
Quarterly vesting schedule - RSUs and PSUs (as percent) 6.25%    
Performance Stock Units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 4 years    
Vesting rights (as percent) 25.00%    
Quarterly vesting schedule - RSUs and PSUs (as percent) 6.25%    
Market-based PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 3 years    
Vesting rights (as percent) 100.00%    
Employee Stock Purchase Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Maximum employee subscription rate (as percent) 15.00%    
Purchase price of ESPP (as percent) 85.00%    
Shares reserved for future issuance (in shares) 227    
v3.24.0.1
Stock-Based Compensation - Equity Incentive Plans (Details)
shares in Millions
12 Months Ended
Jan. 28, 2024
$ / shares
shares
Number of Shares  
RSUs, PSUs and Market-based PSUs, outstanding, beginning balance (in shares) | shares 45
RSUs, PSUs and Market-based PSUs, granted (in shares) | shares 14
RSUs, PSUs and Market-based PSUs, vested (in shares) | shares (21)
RSUs, PSUs and Market-based PSUs, canceled and forfeited (in shares) | shares (1)
RSUs, PSUs and Market-based PSUs, outstanding, ending balance (in shares) | shares 37
Vested and expected to vest, RSUs, PSUs and Market-based PSUs (in shares) | shares 37
Weighted Average Grant-Date Fair Value  
PSUs and Market-based PSUs, weighted average grant date fair value, beginning balance (in USD per share) | $ / shares $ 158.45
PSUs and Market-based PSUs, weighted average grant date fair value, granted (in USD per share) | $ / shares 374.08
PSUs and Market-based PSUs, weighted average grant date fair value, vested (in USD per share) | $ / shares 148.56
PSUs and Market-based PSUs, weighted average grant date fair value, canceled and forfeited (in USD per share) | $ / shares 206.35
PSUs and Market-based PSUs, weighted average grant date fair value, ending balance (in USD per share) | $ / shares 245.94
Vested and expected to vest, RSUs, PSUs and Market-based PSUs, weighted average grant date fair value (in USD per share) | $ / shares $ 245.49
v3.24.0.1
Net Income Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Numerator:      
Net income $ 29,760 $ 4,368 $ 9,752
Denominator:      
Basic weighted average shares (in shares) 2,469 2,487 2,496
Dilutive impact of outstanding equity awards (in shares) 25 20 39
Diluted weighted average shares (in shares) 2,494 2,507 2,535
Net income per share:      
Basic (in USD per share) $ 12.05 $ 1.76 $ 3.91
Diluted (in USD per share) $ 11.93 $ 1.74 $ 3.85
Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive (in shares) 15 40 21
v3.24.0.1
Goodwill (Details) - USD ($)
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Goodwill [Line Items]      
Goodwill $ 4,430,000,000 $ 4,372,000,000  
Goodwill acquired during period 59,000,000    
Goodwill impairment loss 0 0 $ 0
Compute & Networking      
Goodwill [Line Items]      
Goodwill 4,100,000,000 4,000,000,000  
Graphics      
Goodwill [Line Items]      
Goodwill $ 370,000,000 $ 370,000,000  
v3.24.0.1
Amortizable Intangible Assets (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
May 01, 2022
Finite-Lived Intangible Assets [Line Items]        
Gross Carrying Amount $ 3,091 $ 3,539    
Accumulated Amortization (1,979) (1,863)    
Net  Carrying Amount 1,112 1,676    
Amortization expense 614 699 $ 563  
Future amortization expense associated with intangible assets        
Fiscal 2025 555      
Fiscal 2026 261      
Fiscal 2027 150      
Fiscal 2028 37      
Fiscal 2029 9      
Fiscal 2030 and thereafter 100      
Net  Carrying Amount 1,112 1,676    
Acquisition-related intangible assets        
Finite-Lived Intangible Assets [Line Items]        
Gross Carrying Amount 2,642 3,093    
Accumulated Amortization (1,720) (1,614)    
Net  Carrying Amount 922 1,479    
Future amortization expense associated with intangible assets        
Net  Carrying Amount 922 1,479    
Patents and licensed technology        
Finite-Lived Intangible Assets [Line Items]        
Gross Carrying Amount 449 446    
Accumulated Amortization (259) (249)    
Net  Carrying Amount 190 197    
Future amortization expense associated with intangible assets        
Net  Carrying Amount $ 190 $ 197    
In process research and development        
Finite-Lived Intangible Assets [Line Items]        
Gross Carrying Amount       $ 630
v3.24.0.1
Cash Equivalents and Marketable Securities - Cash Equivalents and Marketable Securities (Details) - USD ($)
$ in Millions
Jan. 28, 2024
Jan. 29, 2023
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost $ 25,684 $ 13,112
Unrealized Gain 56 1
Unrealized Loss (16) (58)
Estimated Fair Value 25,724 13,055
Cash Equivalents 7,020 3,148
Marketable Securities 18,704 9,907
Corporate debt securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 10,126 4,809
Unrealized Gain 31 0
Unrealized Loss (5) (12)
Estimated Fair Value 10,152 4,797
Cash Equivalents 2,231 1,087
Marketable Securities 7,921 3,710
Debt securities issued by the U.S. Treasury    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 9,517 4,185
Unrealized Gain 17 1
Unrealized Loss (10) (44)
Estimated Fair Value 9,524 4,142
Cash Equivalents 1,315 0
Marketable Securities 8,209 4,142
Debt securities issued by U.S. government agencies    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 2,326 1,836
Unrealized Gain 8 0
Unrealized Loss (1) (2)
Estimated Fair Value 2,333 1,834
Cash Equivalents 89 50
Marketable Securities 2,244 1,784
Money market funds    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 3,031 1,777
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value 3,031 1,777
Cash Equivalents 3,031 1,777
Marketable Securities 0 0
Certificates of deposit    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 510 365
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value 510 365
Cash Equivalents 294 134
Marketable Securities 216 231
Foreign government bonds    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 174 140
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value 174 140
Cash Equivalents 60 100
Marketable Securities $ 114 $ 40
v3.24.0.1
Cash Equivalents and Marketable Securities - Unrealized Losses Aggregated by Investment Category (Details) - USD ($)
$ in Millions
Jan. 28, 2024
Jan. 29, 2023
Estimated Fair Value    
Less than 12 Months $ 5,319 $ 4,939
12 Months or Greater 1,696 1,868
Total 7,015 6,807
Gross Unrealized Loss    
Less than 12 Months (9) (30)
12 Months or Greater (7) (28)
Total (16) (58)
Debt securities issued by the U.S. Treasury    
Estimated Fair Value    
Less than 12 Months 3,343 2,444
12 Months or Greater 1,078 1,172
Total 4,421 3,616
Gross Unrealized Loss    
Less than 12 Months (5) (21)
12 Months or Greater (5) (23)
Total (10) (44)
Corporate debt securities    
Estimated Fair Value    
Less than 12 Months 1,306 1,188
12 Months or Greater 618 696
Total 1,924 1,884
Gross Unrealized Loss    
Less than 12 Months (3) (7)
12 Months or Greater (2) (5)
Total (5) (12)
Debt securities issued by U.S. government agencies    
Estimated Fair Value    
Less than 12 Months 670 1,307
12 Months or Greater 0 0
Total 670 1,307
Gross Unrealized Loss    
Less than 12 Months (1) (2)
12 Months or Greater 0 0
Total $ (1) $ (2)
v3.24.0.1
Cash Equivalents and Marketable Securities - Amortized Cost and Estimated Fair Value of Cash Equivalents and Marketable Securities (Details) - USD ($)
$ in Millions
Jan. 28, 2024
Jan. 29, 2023
Amortized Cost    
Less than one year $ 16,336 $ 9,738
Due in 1 - 5 years 9,348 3,374
Amortized Cost 25,684 13,112
Estimated Fair Value    
Less than one year 16,329 9,708
Due in 1 - 5 years 9,395 3,347
Estimated Fair Value $ 25,724 $ 13,055
v3.24.0.1
Fair Value of Financial Assets and Liabilities and Investments in Non-Affiliated Entities (Details) - USD ($)
$ in Millions
Jan. 28, 2024
Jan. 29, 2023
Assets    
Cash equivalents and marketable securities $ 25,724 $ 13,055
Investments in non-affiliated entities $ 1,546 299
0.309% Notes Due 2023    
Financial assets and liabilities measured at fair value    
Interest rate (as percent) 0.309%  
0.584% Notes Due 2024    
Financial assets and liabilities measured at fair value    
Interest rate (as percent) 0.584%  
3.20% Notes Due 2026    
Financial assets and liabilities measured at fair value    
Interest rate (as percent) 3.20%  
1.55% Notes Due 2028    
Financial assets and liabilities measured at fair value    
Interest rate (as percent) 1.55%  
2.85% Notes Due 2030    
Financial assets and liabilities measured at fair value    
Interest rate (as percent) 2.85%  
2.00% Notes Due 2031    
Financial assets and liabilities measured at fair value    
Interest rate (as percent) 2.00%  
3.50% Notes Due 2040    
Financial assets and liabilities measured at fair value    
Interest rate (as percent) 3.50%  
3.50% Notes Due 2050    
Financial assets and liabilities measured at fair value    
Interest rate (as percent) 3.50%  
3.70% Notes Due 2060    
Financial assets and liabilities measured at fair value    
Interest rate (as percent) 3.70%  
Level 1 | Money market funds    
Assets    
Cash equivalents and marketable securities $ 3,031 1,777
Level 1 | Publicly-held equity securities    
Assets    
Investments in non-affiliated entities 225 11
Level 2 | 0.309% Notes Due 2023    
Liabilities    
Long-term debt 0 1,230
Level 2 | 0.584% Notes Due 2024    
Liabilities    
Long-term debt 1,228 1,185
Level 2 | 3.20% Notes Due 2026    
Liabilities    
Long-term debt 970 966
Level 2 | 1.55% Notes Due 2028    
Liabilities    
Long-term debt 1,115 1,099
Level 2 | 2.85% Notes Due 2030    
Liabilities    
Long-term debt 1,367 1,364
Level 2 | 2.00% Notes Due 2031    
Liabilities    
Long-term debt 1,057 1,044
Level 2 | 3.50% Notes Due 2040    
Liabilities    
Long-term debt 851 870
Level 2 | 3.50% Notes Due 2050    
Liabilities    
Long-term debt 1,604 1,637
Level 2 | 3.70% Notes Due 2060    
Liabilities    
Long-term debt 403 410
Level 2 | Corporate debt securities    
Assets    
Cash equivalents and marketable securities 10,152 4,797
Level 2 | Debt securities issued by the U.S. Treasury    
Assets    
Cash equivalents and marketable securities 9,524 4,142
Level 2 | Debt securities issued by U.S. government agencies    
Assets    
Cash equivalents and marketable securities 2,333 1,834
Level 2 | Certificates of deposit    
Assets    
Cash equivalents and marketable securities 510 365
Level 2 | Foreign government bonds    
Assets    
Cash equivalents and marketable securities $ 174 $ 140
v3.24.0.1
Fair Value of Financial Assets and Liabilities and Investments in Non-Affiliated Entities - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Financial assets and liabilities measured at fair value    
Investments in non-affiliated entities $ 1,546 $ 299
Unrealized gains 178  
Adjustment, cumulative amount 174  
Publicly-held equity securities | Level 1    
Financial assets and liabilities measured at fair value    
Investments in non-affiliated entities 225 11
Privately-held equity securities | Level 3    
Financial assets and liabilities measured at fair value    
Investments in non-affiliated entities $ 1,300 $ 288
v3.24.0.1
Fair Value of Financial Assets and Liabilities and Investments in Non-Affiliated Entities - Carrying Value of Non-marketable Equity Securities (Details)
$ in Millions
12 Months Ended
Jan. 28, 2024
USD ($)
Investments, Debt and Equity Securities [Abstract]  
Carrying amount, beginning $ 288
Net additions 859
Unrealized gains 194
Impairments and unrealized losses (20)
Carrying amount, ending $ 1,321
v3.24.0.1
Fair Value of Financial Assets and Liabilities and Investments in Non-Affiliated Entities - Cumulative Gross (Details)
$ in Millions
Jan. 28, 2024
USD ($)
Investments, Debt and Equity Securities [Abstract]  
Adjustment, cumulative amount $ 270
Cumulative gross unrealized losses and impairments $ (45)
v3.24.0.1
Balance Sheet Components - Inventories (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Inventories    
Raw materials $ 1,719 $ 2,430
Work in-process 1,505 466
Finished goods 2,058 2,263
Total inventories 5,282 5,159
Inventory reserves expenses $ 774 $ 1,000
v3.24.0.1
Balance Sheet Components - Property and Equipment (Details) - USD ($)
$ in Millions
Jan. 28, 2024
Jan. 29, 2023
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 7,423 $ 6,501
Accumulated depreciation and amortization (3,509) (2,694)
Total property and equipment, net $ 3,914 3,807
Minimum    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 3 years  
Maximum    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 7 years  
Land    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 218 218
Buildings, leasehold improvements, and furniture    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross 1,816 1,598
Equipment, compute hardware, and software    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 5,200 4,303
Equipment, compute hardware, and software | Minimum    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 3 years  
Equipment, compute hardware, and software | Maximum    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 7 years  
Construction in process    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 189 $ 382
Buildings    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 30 years  
v3.24.0.1
Balance Sheet Components - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Property, Plant and Equipment [Line Items]      
Depreciation expense $ 894 $ 844 $ 611
Accumulated amortization of lease hold improvements and capital lease 400 327  
Capital expenditures incurred but not yet paid 170 374 $ 258
Deferred revenue $ 338 $ 282  
Significant Customer | Accounts Receivable | Customer Concentration Risk      
Property, Plant and Equipment [Line Items]      
Concentration risk (as percent) 24.00% 14.00%  
Two Customers | Accounts Receivable | Customer Concentration Risk      
Property, Plant and Equipment [Line Items]      
Concentration risk (as percent) 11.00% 11.00%  
v3.24.0.1
Balance Sheet Components - Other Assets (Details) - USD ($)
$ in Millions
Jan. 28, 2024
Jan. 29, 2023
Supply Commitment [Line Items]    
Prepaid supply and capacity agreements $ 2,458 $ 2,989
Investments in non-affiliated entities 1,546 299
Prepaid royalties 364 387
Other 132 145
Other assets 4,500 3,820
Prepaid expenses and other current assets 3,080 791
Supply and Capacity Agreements    
Supply Commitment [Line Items]    
Prepaid expenses and other current assets $ 2,500 $ 458
v3.24.0.1
Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Accrued and Other Current Liabilities:      
Customer program accruals $ 2,081 $ 1,196  
Excess inventory purchase obligations 1,655 954  
Deferred revenue 764 354  
Accrued payroll and related expenses 675 530  
Product warranty and return provisions 415 108  
Taxes payable $ 296 $ 467  
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Accrued and other current liabilities Accrued and other current liabilities  
Operating leases $ 228 $ 176  
Unsettled share repurchases 187 117  
Licenses and royalties 182 149  
Other 199 69  
Accrued and other current liabilities 6,682 4,120  
Cost of revenue 16,621 11,618 $ 9,439
Inventory purchase obligations in excess of projections      
Accrued and Other Current Liabilities:      
Cost of revenue 1,400 1,100  
Customer advances      
Accrued and Other Current Liabilities:      
Deferred revenue $ 233 $ 35  
v3.24.0.1
Balance Sheet Components - Other Long-Term Liabilities (Details) - USD ($)
$ in Millions
Jan. 28, 2024
Jan. 29, 2023
Other Long-Term Liabilities:    
Income tax payable $ 1,361 $ 1,204
Deferred income tax 462 247
Deferred revenue 573 218
Licenses payable 80 181
Other 65 63
Total other long-term liabilities $ 2,541 $ 1,913
v3.24.0.1
Balance Sheet Components - Deferred Revenue (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Movement in Deferred Revenue [Roll Forward]    
Balance at beginning of period $ 572 $ 502
Deferred revenue additions during the period 2,038 830
Revenue recognized during the period (1,273) (760)
Balance at end of period $ 1,337 $ 572
v3.24.0.1
Balance Sheet Components - Revenue Remaining Performance Obligation (Details)
$ in Billions
Jan. 28, 2024
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligation $ 1.1
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-29  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligation (as percent) 40.00%
Expected performance period 12 months
v3.24.0.1
Derivative Financial Instruments - Notional Value of Our Foreign Currency Forward Contracts Outstanding (Details) - Foreign currency forward contract - USD ($)
$ in Millions
Jan. 28, 2024
Jan. 29, 2023
Designated as Hedging Instrument    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Notional values of derivative contracts $ 1,168 $ 1,128
Not Designated as Hedging Instrument    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Notional values of derivative contracts $ 597 $ 366
v3.24.0.1
Derivative Financial Instruments - Narrative (Details)
12 Months Ended
Jan. 28, 2024
Foreign currency forward contract  
Derivative [Line Items]  
Maximum maturity period 18 months
v3.24.0.1
Debt - Narrative (Details) - USD ($)
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Debt Instrument [Line Items]      
Proceeds from issuance of bet, net of issuance costs $ 0 $ 0 $ 4,977,000,000
Repayment of debt 1,250,000,000 $ 0 $ 1,000,000,000
Outstanding commercial paper 0    
Commercial Paper      
Debt Instrument [Line Items]      
Maximum borrowing capacity $ 575,000,000    
0.309% Notes Due 2023      
Debt Instrument [Line Items]      
Stated interest rate (percent) 0.309%    
v3.24.0.1
Debt - Schedule of Debt (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Debt Instrument [Line Items]    
Unamortized debt discount and issuance costs $ (41) $ (47)
Net carrying amount 9,709 10,953
Less short-term portion (1,250) (1,250)
Long-term debt $ 8,459 9,703
0.309% Notes Due 2023    
Debt Instrument [Line Items]    
Interest rate (as percent) 0.309%  
Effective Interest Rate (as percent) 0.41%  
Gross carrying amount $ 0 1,250
0.584% Notes Due 2024    
Debt Instrument [Line Items]    
Interest rate (as percent) 0.584%  
Expected Remaining Term (years) 4 months 24 days  
Effective Interest Rate (as percent) 0.66%  
Gross carrying amount $ 1,250 1,250
3.20% Notes Due 2026    
Debt Instrument [Line Items]    
Interest rate (as percent) 3.20%  
Expected Remaining Term (years) 2 years 7 months 6 days  
Effective Interest Rate (as percent) 3.31%  
Gross carrying amount $ 1,000 1,000
1.55% Notes Due 2028    
Debt Instrument [Line Items]    
Interest rate (as percent) 1.55%  
Expected Remaining Term (years) 4 years 4 months 24 days  
Effective Interest Rate (as percent) 1.64%  
Gross carrying amount $ 1,250 1,250
2.85% Notes Due 2030    
Debt Instrument [Line Items]    
Interest rate (as percent) 2.85%  
Expected Remaining Term (years) 6 years 2 months 12 days  
Effective Interest Rate (as percent) 2.93%  
Gross carrying amount $ 1,500 1,500
2.00% Notes Due 2031    
Debt Instrument [Line Items]    
Interest rate (as percent) 2.00%  
Expected Remaining Term (years) 7 years 4 months 24 days  
Effective Interest Rate (as percent) 2.09%  
Gross carrying amount $ 1,250 1,250
3.50% Notes Due 2040    
Debt Instrument [Line Items]    
Interest rate (as percent) 3.50%  
Expected Remaining Term (years) 16 years 2 months 12 days  
Effective Interest Rate (as percent) 3.54%  
Gross carrying amount $ 1,000 1,000
3.50% Notes Due 2050    
Debt Instrument [Line Items]    
Interest rate (as percent) 3.50%  
Expected Remaining Term (years) 26 years 2 months 12 days  
Effective Interest Rate (as percent) 3.54%  
Gross carrying amount $ 2,000 2,000
3.70% Notes Due 2060    
Debt Instrument [Line Items]    
Interest rate (as percent) 3.70%  
Expected Remaining Term (years) 36 years 2 months 12 days  
Effective Interest Rate (as percent) 3.73%  
Gross carrying amount $ 500 $ 500
v3.24.0.1
Commitments and Contingencies - Narrative (Details) - USD ($)
$ in Millions
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Supply Commitment [Line Items]        
Inventory purchase and long-term supply agreements $ 16,100      
Other purchase obligations 4,600      
Warranty accrual 306 $ 82 $ 46 $ 22
License and Service        
Supply Commitment [Line Items]        
Other purchase obligations $ 3,500      
v3.24.0.1
Commitments and Contingencies - Summary of Future Commitments Due by Year (Details)
$ in Millions
Jan. 28, 2024
USD ($)
Fiscal Year:  
2025 $ 17,316
2026 1,143
2027 1,060
2028 770
2029 and thereafter 418
Total $ 20,707
v3.24.0.1
Commitments and Contingencies - Schedule of Product Warranty Liabilities (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]      
Beginning Balance $ 82 $ 46 $ 22
Additions 278 145 40
Utilization (54) (109) (16)
Ending Balance $ 306 $ 82 $ 46
v3.24.0.1
Income Taxes - Components of Income Tax Expense (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Current income taxes:      
Federal $ 5,710 $ 1,703 $ 482
State 335 46 42
Foreign 502 228 71
Total current 6,547 1,977 595
Deferred income taxes:      
Federal (2,499) (2,165) (420)
State (206) 0 0
Foreign 216 1 14
Total deferred (2,489) (2,164) (406)
Income tax expense (benefit) 4,058 (187) 189
Income before Income Taxes      
U.S. 29,495 3,477 8,446
Foreign 4,323 704 1,495
Income before income tax $ 33,818 $ 4,181 $ 9,941
v3.24.0.1
Income Taxes - Income Tax Reconciliation (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]      
Tax expense computed at federal statutory rate $ 7,102 $ 878 $ 2,088
State income taxes, net of federal tax effect 120 50 42
Foreign-derived intangible income (1,408) (739) (520)
Stock-based compensation (741) (309) (337)
Foreign tax rate differential (467) (83) (497)
U.S. federal research and development tax credit (431) (278) (289)
Acquisition termination cost 0 261 0
IP domestication 0 0 (244)
Other (117) 33 (54)
Income tax expense (benefit) $ 4,058 $ (187) $ 189
Effective Income Tax Rate Reconciliation, Percent [Abstract]      
Tax expense computed at federal statutory rate 21.00% 21.00% 21.00%
State income taxes, net of federal tax effect 0.40% 1.20% 0.40%
Foreign-derived intangible income (4.20%) (17.70%) (5.20%)
Stock-based compensation (2.20%) (7.40%) (3.40%)
Foreign tax rate differential (1.40%) (2.00%) (5.00%)
U.S. federal research and development tax credit (1.30%) (6.60%) (2.90%)
Acquisition termination cost 0 0.062 0
IP domestication 0 0 (0.025)
Other (0.30%) 0.80% (0.50%)
Effective tax rate (as percent) 12.00% (4.50%) 1.90%
v3.24.0.1
Income Taxes - Deferred Taxes (Details) - USD ($)
$ in Millions
Jan. 28, 2024
Jan. 29, 2023
Deferred tax assets:    
Capitalized research and development expenditure $ 3,376 $ 1,859
GILTI deferred tax assets 1,576 800
Accruals and reserves, not currently deductible for tax purposes 1,121 686
Research and other tax credit carryforwards 936 951
Net operating loss and capital loss carryforwards 439 409
Operating lease liabilities 263 193
Stock-based compensation 106 99
Property, equipment and intangible assets 4 66
Other deferred tax assets 179 91
Gross deferred tax assets 8,000 5,154
Less valuation allowance (1,552) (1,484)
Total deferred tax assets 6,448 3,670
Deferred tax liabilities:    
Unremitted earnings of foreign subsidiaries (502) (228)
Operating lease assets (255) (179)
Acquired intangibles (74) (115)
Gross deferred tax liabilities (831) (522)
Net deferred tax asset 5,617 3,148
Deferred tax assets, noncurrent    
Deferred tax assets:    
Gross deferred tax assets 6,100 3,400
Other long-term liabilities    
Deferred tax liabilities:    
Gross deferred tax liabilities $ (462) $ (247)
v3.24.0.1
Income Taxes - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Income Tax Contingency [Line Items]      
Valuation allowance $ 1,552 $ 1,484  
Deferred tax assets 8,000 5,154  
Deferred tax liabilities 831 522  
Unrecognized tax benefits that would affect effective tax rate 1,000    
Interest and taxes recognized related to unrecognized tax benefits 42 33 $ 14
Interest and penalties accrued 140 95  
Other long-term liabilities      
Income Tax Contingency [Line Items]      
Deferred tax liabilities 462 247  
Deferred tax assets, noncurrent      
Income Tax Contingency [Line Items]      
Deferred tax assets 6,100 $ 3,400  
Israel | Mellanox Technologies, Ltd      
Income Tax Contingency [Line Items]      
Undistributed earnings of foreign subsidiaries 1,100    
United Kingdom | Mellanox Technologies, Ltd      
Income Tax Contingency [Line Items]      
Undistributed earnings of foreign subsidiaries 250    
Federal      
Income Tax Contingency [Line Items]      
Net operating loss carryforwards 315    
Research tax credit carryforwards 31    
Federal | Capital Loss Carryforward      
Income Tax Contingency [Line Items]      
Federal capital loss carryforwards 1,400    
Foreign Country      
Income Tax Contingency [Line Items]      
Net operating loss carryforwards 361    
State and Local Jurisdiction      
Income Tax Contingency [Line Items]      
Net operating loss carryforwards 342    
Research tax credit carryforwards 1,600    
California      
Income Tax Contingency [Line Items]      
Research tax credit carryforwards 1,500    
Other states      
Income Tax Contingency [Line Items]      
Research tax credit carryforwards $ 75    
v3.24.0.1
Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Balance at beginning of period $ 1,238 $ 1,013 $ 776
Increases in tax positions for current year 616 268 246
Increases in tax positions for prior years 87 1 14
Decreases in tax positions for prior years (148) (15) (4)
Settlements (104) (9) (8)
Lapse in statute of limitations (19) (20) (11)
Balance at end of period 1,670 $ 1,238 $ 1,013
Unrecognized tax benefits that would affect effective tax rate $ 1,000    
v3.24.0.1
Shareholders' Equity (Details) - USD ($)
shares in Millions, $ in Millions
1 Months Ended 12 Months Ended
Feb. 16, 2024
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Aug. 31, 2023
Equity, Class of Treasury Stock [Line Items]          
Number of share repurchased (in shares)   21.0      
Shares repurchased   $ 9,746 $ 10,039    
Additional number of shares authorized to be repurchased         $ 25,000
Stock repurchase program, authorized amount   22,500      
Dividends paid   395 398 $ 399  
Retirement of treasury stock (in shares)       349.0  
Retirement of treasury stock       $ 0  
Subsequent Event          
Equity, Class of Treasury Stock [Line Items]          
Number of share repurchased (in shares) 2.8        
Shares repurchased $ 1,900        
Additional Paid-in Capital          
Equity, Class of Treasury Stock [Line Items]          
Shares repurchased   27 4    
Retirement of treasury stock       20  
Retained Earnings          
Equity, Class of Treasury Stock [Line Items]          
Shares repurchased   $ 9,719 $ 10,034    
Retirement of treasury stock       $ 12,026  
v3.24.0.1
Employee Retirement Plans (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Retirement Benefits [Abstract]      
Defined contribution plan costs $ 255 $ 227 $ 168
v3.24.0.1
Segment Information - Narrative (Details) - segment
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Segment Reporting Information [Line Items]      
Number of reportable segments 2    
Revenue | Customer Concentration Risk | Significant Customer      
Segment Reporting Information [Line Items]      
Concentration risk (as percent) 13.00%    
Revenue | Customer Concentration Risk | Non-US      
Segment Reporting Information [Line Items]      
Concentration risk (as percent) 56.00% 69.00% 84.00%
v3.24.0.1
Segment Information - Reportable Segments (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Segment Reporting Information [Line Items]      
Revenue $ 60,922 $ 26,974 $ 26,914
Operating income (loss) 32,972 4,224 10,041
All Other      
Segment Reporting Information [Line Items]      
Revenue 0 0 0
Operating income (loss) (4,890) (5,411) (3,049)
Graphics | Operating segments      
Segment Reporting Information [Line Items]      
Revenue 13,517 11,906 15,868
Operating income (loss) 5,846 4,552 8,492
Compute & Networking | Operating segments      
Segment Reporting Information [Line Items]      
Revenue 47,405 15,068 11,046
Operating income (loss) $ 32,016 $ 5,083 $ 4,598
v3.24.0.1
Segment Information - Reconciling Items (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Segment Reporting Information [Line Items]      
Stock-based compensation expense $ (3,549) $ (2,709) $ (2,004)
Operating income 32,972 4,224 10,041
All Other      
Segment Reporting Information [Line Items]      
Stock-based compensation expense (3,549) (2,710) (2,004)
Unallocated cost of revenue and operating expenses (728) (595) (399)
Acquisition termination cost 0 (1,353) 0
Acquisition-related and other costs (583) (674) (636)
IP-related and legal settlement costs (40) (23) (10)
Restructuring costs and other 0 (54) 0
Other 10 (2) 0
Operating income $ (4,890) $ (5,411) $ (3,049)
v3.24.0.1
Segment Information - Revenue and Long-lived Assets by Region (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Revenues and Long-Lived Assets      
Revenue $ 60,922 $ 26,974 $ 26,914
Long-lived assets 3,914 3,807  
United States      
Revenues and Long-Lived Assets      
Revenue 26,966 8,292 4,349
Long-lived assets 2,595 2,587  
Taiwan      
Revenues and Long-Lived Assets      
Revenue 13,405 6,986 8,544
Long-lived assets 773 702  
China (including Hong Kong)      
Revenues and Long-Lived Assets      
Revenue 10,306 5,785 7,111
Israel      
Revenues and Long-Lived Assets      
Long-lived assets 325 283  
Other countries      
Revenues and Long-Lived Assets      
Revenue 10,245 5,911 $ 6,910
Long-lived assets $ 221 $ 235  
v3.24.0.1
Segment Information - Schedule of Revenue by Market (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Revenue from External Customer [Line Items]      
Revenue $ 60,922 $ 26,974 $ 26,914
Data Center      
Revenue from External Customer [Line Items]      
Revenue 47,525 15,005 10,613
Gaming      
Revenue from External Customer [Line Items]      
Revenue 10,447 9,067 12,462
Professional Visualization      
Revenue from External Customer [Line Items]      
Revenue 1,553 1,544 2,111
Automotive      
Revenue from External Customer [Line Items]      
Revenue 1,091 903 566
OEM and Other      
Revenue from External Customer [Line Items]      
Revenue $ 306 $ 455 $ 1,162
v3.24.0.1
Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Allowance for doubtful accounts      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period $ 4 $ 4 $ 4
Additions 0 0 0
Deductions 0 0 0
Balance at End of Period 4 4 4
Sales return allowance      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 26 13 17
Additions 213 104 19
Deductions (130) (91) (23)
Balance at End of Period 109 26 13
Deferred tax valuation allowance      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 1,484 907 728
Additions 162 577 179
Deductions (94) 0 0
Balance at End of Period $ 1,552 $ 1,484 $ 907